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TABLE II
Year Bed-days saved
2007        67
2008      215
2009      609
2.
UsE of ThE ELcAm mEdIcAL cAThETEr TIp LocATor sYsTEm (ThE 
cATfIndEr) To dETErmInE cAThETEr TIp LocATIon In 131 pATIEnTs 
Sansivero, Gail1; Siskin, Gary2; Mitchell, Nancy3; Doti, Christopher2;        
Reutzel, Laura2; Barnea, Ofer4
1Community Care Physicians, Interventional Radiology, Albany, New 
York, USA
2Community Care Physicians, Interventional Radiology, Albany, New 
York, USA
3Community Care Physicians, Interventional Radiology, Albany, New 
York, USA
4Tel Aviv University, Biomedical Engineering, Ramat Aviv, Israel
Introduction: Verification of catheter tip location for central vascular ac-
cess devices is required prior to initiating infusion therapy. The CatFinder 
(Elcam Medical, BarAm, Israel) is a non-invasive system intended to assist 
in catheter tip localization during placement of peripherally inserted cen-
tral catheters (PICCs). This study was performed to correlate the fluoroscopic 
post-placement tip location of PICCs with the tip position predicted using 
the CatFinder.
Method: This was a single center, prospective, non-randomized trial evaluat-
ing tip position after PICC placement. Following initial ultrasound guided 
upper extremity venous access, a central venogram was performed to evalu-
ate for central stenoses and/or thrombosis, and to identify the atriocaval junc-
tion. As the PICC was advance to the atriocaval junction, it was connected 
externally to the CatFinder device. ECG leads and a transducer were used to 
measure venous pressure. As the PICC was advanced centrally in 2.5cm in-
tervals, the system analyzed the delay between the two signals and converted 
that to distance from teh atriocaval junction. The threshold point for success 
was considered 2.5cm (+/-1.5cm) from the atriocaval junction. Results: 131 
patients were enrolled in the study (mean age 54.7yrs, range 19-86yrs). The 
most common indications for PICC placement included infection (n=86) and 
cancer (n=23). All patients received either a 5F or 6F device. There were no 
complications during PICC placement. Using the threshold point as defined, 
the success rate of predicting the PICC tip position within 2.5cm of the atrio-
caval junction was 95.4%. 
Discussion & Conclusion: The Elcam Medical Catheter Tip Locator System 
(the CatFinder) appears to be an accurate system for PICC tip localization. 
Further investigation to validate the system on smaller devices is needed. 
3.
cLInIcAL mAnAgEmEnT of pIcc TEchnIqUE 
Wang, LiJuan
Beijing Chest Hospital, Beijing, China
Beijing Chest Hospital, affiliated to Capital University of Medical Sciences, 
is a specialist hospital of tuberculosis and thoracic tumour that set clinic, 
research and teaching in one body. Patients who are admitted to our hospital 
are mainly thoracic tumour and tuberculosis patients mostly with a longer 
1. 
To oncoLogY And BEYond! how An ULTrAsoUnd gUIdEd pIcc 
InsErTIon sErvIcE hAs BEnEfITEd non-oncoLogY pATIEnTs In A 
UK hospITAL 
Nicholson, Jackie
The Royal Surrey County Hospital NHS Foundation Trust, Intravenous 
Therapy, Lavis Suite The Royal Surrey County Hospital, Guildford, UK
Introduction: The use of the Peripherally Inserted Central Catheter (PICC) has 
gained popularity over the last 30 years in the United States (US) and now 
become an important form of vascular access in many parts of the world. In 
the 1990’s nurses in the US began to place PICCs using ultrasound guidance 
(Moureau 2006) and development of these techniques has greatly enhanced 
PICC insertion services with studies showing improved success rates and re-
duced complications (Simcock 2008). PICC insertion services have devel-
oped in the UK over the last 15 years and were initially used for the deliv-
ery of parental nutrition (PN) (Hamilton 2005) and chemotherapy, (Gabriel 
2003). Subsequent developments saw the use of PICCs in the community 
(Kayley 2003) and the adoption of ultrasound guided techiniques. An ultra-
sound guided PICC insertion service was set up in a district general hospital 
for non-oncology patients. It was expected that the greatest users of the ser-
vice would be patients requiring PN. Retrospective audit has shown however, 
that the largest group of patients to benefit from the PICC insertion service 
have been those with difficult venous access. Discussion of the results of this 
audit, will show the distribution of PICC insertion categories along with some 
specific clinical considerations and associated benefits to the hospital Trust. 
Method: A retrospective audit was completed using a convenience sample 
of all patients receiving a PICC over a 3 year period. Data was collected at 
the time of each insertion and included the reason that the PICC was being 
inserted. Results 119 non-oncology patients required PICC insertion over the 
audit period with the distribution of categories as follows (Tab. I) 
Discussion: The total number of patients receiving a PICC because of difficult 
venous access was 62 representing 52% of the total number of PICC place-
ments. Patients with difficult venous access included those with fragile veins, 
non-palpable veins, damaged veins (due to previous chemotherapy or IV 
drug abuse), obesity and oedema. The next largest category with 35 patients 
representing 29% of the total placements was patients receiving IV therapy 
in the community. The benefits of this service included an improved patient 
experience, reduced risk of acquiring a healthcare associated infection and 
the release of acute beds to the hospital Trust. Over the study period bed-day 
savings increased from 67 in year 1 to 609 in year 3 (Tab. II) 
Conclusion: The development of an ultrasound guided PICC insertion service 
has benefited many non-oncology patients in a district general hospital set-
ting. Patients who would otherwise have had difficulty in receiving intrave-
nous therapy due to difficult venous access have been significantly helped by 
the service (Tab. I). Patients have also been able to leave hospital earlier to 
continue intravenous therapy in the community and the saving of bed days 
has released valuable resources to the hospital Trust (Tab. II) 
TABLE I
reason for pIcc insertion number of patients percentage of total
Difficult venous access 51 43%
Difficult venous access and PN 11 9%
PN 9 8%
Mid to long term IV therapy 13 11%
IV therapy in the community 35 29%
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5.
ImprovIng AnTIBIoTIc TrEATmEnT oUTcomEs ThroUgh ThE 
ImpLEmEnTATIon of A mIdLInE: pILoTIng A chAngE In prAcTIcE 
for cYsTIc fIBrosIs pATIEnTs 
Cummings, Melita; Hearse, Neville
Royal Adelaide Hospital, Department of Radiology, Adelaide, Australia
Introduction: Evidence suggests that peripherally inserted central catheter use 
in cystic fibrosis patients leads to superior vena cava obstruction/occlusion 
and establishment of chest collateral vessels, potentially precluding patients 
from receiving a lung transplant. Drawing on the current ‘Guidelines for the 
Prevention of Intravascular Catheter-Related Infections’ and a review of re-
search evidence, midline use was re-examined in a cystic fibrosis control 
group. The aim was to establish whether the use of midlines improved treat-
ment outcomes in this patient group. 
Method: A cost analysis emphasizing known infection rates, cost benefit and 
a reduction in patients requiring multiple lines was submitted to the hospital. 
Following ethical approval, 42 inpatients with cystic fibrosis were identified 
and informed of the trial and possible risks of midline use. Patients were re-
quested to report early signs of infection to the cystic fibrosis nurse coor-
dinator. Lines were checked daily until removal. All midline tips were sent 
for culture on removal and data from the 42 midlines placed in 2006 were 
retrieved from the hospital scientist for analysis. 
Results: On conclusion of the trial, data demonstrated both zero infection and 
thrombus rates in the patient population. Midlines were continually moni-
tored for a further 12 months following conclusion of the trial and infection 
rates continued to be below 1% and thrombus rates lower than 2%. 
Discussion & Conclusion: Midlines have many advantages for chronically 
ill patients needing two to four weeks of intravenous therapy and medica-
tions, and when inserted in a sterile environment and correctly monitored 
and maintained, have a significantly lower association of infection and 
thrombus than previously suggested. Due to a reduction in central collateral 
vessel formation from incursions into the superior vena cava, outcomes for 
cystic fibrosis patients requiring lung transplant may also improve.
6.
BEdsIdE vErsUs dEdIcATEd AmBULATorY for pIccs pLAcEmEnT. 
1000 cAsEs AnALIzEd
 
Mussa, Baudolino; Pischedda, Franco; Garrino, Cristina; Degiorgis, Claudia
University of Turin, DDMC, Turin, Italy
In our institution since 2006 we implanted PICCs for nutritional and intrave-
nous therapy use. From June 2009 a bedside implantation team was created to 
implantation of PICCs and not tunneled Cvc in not transportable patients, in 
critical patients and in septic patients. From June 2009 to February 2010 we 
implanted 718 PICCs. 334 bedside, 384 in dedicated facility. We analyzed 
implantation difficulty and implant related complications to evaluate difference 
between logistical situations. Devices, procedures and guidelines are the same. 
Also echographic device used is the same type. We individuated as parameters 
of logistical related complications the procedure failure, the medium number 
of vein puncture, the primary tips wrong position and the first 7 days cvc related 




Medium n° of punctures 1.2 1.3
Primary tip wrong position 18 24
Sepsis 1 1
Medium time (min) 48 29
Medium difficulty score (1-10) 6 4
Our analysis demonstrate that for a specialized team bedside implantation has 
the same quality of ambulatory implantation but requested more time and it is 
more difficult. We suggest to reserve this procedure only for selected patients.
course of disease. In order to avoid the damage from the long-term infusion 
of chemotherapeutic agents and irritating drugs to peripheral superficial vein, 
nursing department has sent nursing backbones and head nurses out to learn 
and organized hospital training since PICC technique was introduced into 
our hospital in 2003. Now Our hospital already has a group of high-level 
experts on tube insertion and maintenance, established a scientific system 
of clinical management system, and become the designated PICC technique 
training base . Our hospital has trained large numbers of students from across 
the country. Peripherally inserted central catheter (PICC) technique is a tube 
indwelling technique of peripheral intravenous to the central venous. It is 
applicable to the patient intravenous infusion of antibiotics, irritating drugs, 
chemotherapeutic agents or total parenteral nutrition for a long time (more 
than 5d). Because of its simple operation (small puncture wound, high suc-
cess rate) good safety and retention for a long time, PICC not only reduces the 
suffering caused by repeated puncture, but also avoids the damage of drugs to 
peripheral venous. PICC technique establishes a safe and convenient venous 
pathway for patients requiring long-term venous transfusion, brings innova-
tion and development of intravenous infusion method of idea and also im-
proves the work efficiency of nurses. Now it is widely used in our hospital.
4.
EvALUATIon of TrAInIng In vAscULAr AccEss for nUrsIng 
sTUdEnTs 
Montealegre Sanz, Maria1; De La Torre Montero, Julio Cesar1; Jimenez-
Garza, Octavio2; Elvira Elvira, Maria Carmen3; Gonzalez Martin, Miriam4; 
De Grado Mateos, Cristina4
1Hospital Clinico San Carlos, Medical Oncology, Profesor Martin Lagos Sn, 
Madrid, Spain; 2Universidad De Guanajuato, Mexico; 3American School Of 
Madrid, Spain; 4Universidad Complutense, Spain
Introduction: The training of nursing students in basic skills is essential for 
the development of good professionals in the future. We emphasize the need 
for better structuring the basis and scientific knowledge of students and their 
training in nursing and academic standards at university level, rather than dif-
ferent levels of heterogeneous and unstructured knowledge. 
Methods: Surveys have been conducted at 29 nursing students selected by their 
place of practice in the later years of degree from the University Complutense 
of Madrid, in Spain, the issues are closed answer, value of 1 to 10 agreed with 
the following statements: 1. In the current nursing care study plans have exten-
sive training in vascular access. 2. In the training period we have enough time 
to train properly in venous access. 3. We distinguish a perfectly good venous 
access for a not so good. 4. In the training period we have enough time to 
train in blood samples. 5. Nurses are prepared to channel central venous ac-
cess. We also conducted a survey in universities from different countries of our 
European environment, as well as North America (Mexico and United States), 
asking teachers spend many hours in their teaching practice venous access, 
both theoretical and practical hours, not counting hospital practices.
Results: For nursing students questions are on average results for all five is-
sues: 1. Average rating (AR): 6.34; standard deviation (SD) 1,987; 2: AR 6.07; 
SD 2,434;3. AR 8.14; SD 1,457; 4. AR: 6.41; SD 2,758; 5. AR 4.28; SD 2,016 
The question of nursing teachers from different countries on the average num-
ber of hours dedicated to training has resulted in a commitment of 3.5 hours 
classroom theory and 4.3 hours spent in practice in simulators. It should be 
noted that Portugal has a comprehensive plan and that Ireland is now living 
his education implementation plan. 
Conclusions: Knowledge of venous access, both at the level of anatomical knowl-
edge, are in deficit during the period of university studies, specially in central 
venous access, with the result that new nursing graduates arrive at the beginning 
of his professional life as nurses with a knowledge deficit high, for a techniques, 
which surely will have to apply in large measure a large number of patients. 
Discussion: Nursing skills that contain a high level practical weight are often 
neglected in the curricula of many universities, leaving the fate of the student, 
if not its motivation and the carrying out further so essential technique in 
patient care as venepuncture for blood specimen collection and channelling 
of channels for intravenous infusion therapies. Although supervised hospital 
practices, the need to implement specific training plans for undergraduates 
and even graduate, is fundamental to modern nursing.
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and to the interventional radiology departments of a university hospital for 
placement of dual lumen PICCs were screened for entry into the trial. All 
patients received 5Fr dual lumen SecurAcath PICCs. PICCs were placed in the 
interventional radiology suite with tip placement confirmed with fluoroscopy. 
Adult patients were enrolled with a mean age of 56.46 years (range 20-77). 
There were 25 were females and 25 were males. Reasons for PICC placement 
included IVAB therapy, repeated venous sampling , lack of peripheral access, 
IV fluids, TPN, blood products and chemotherapy with many patients having 
multiple indications. The majority of PICCs were placed in the basilic vein.
Results: Time required for deployment of the securement mechanism aver-
aged 11.6 seconds with a range of 5-120 seconds and a median of 10 sec-
onds. Mean PICC dwell time was 19.08 days with a range of 0-125 days. 13 
patients (26%)received both in hospital and at home or alternate care setting 
services. 78% of PICCs were removed at completion of therapy. 22% were 
removed for other reasons including 3 removed for discomfort at the site, 2 
for deep vein thrombosis and others for oedema (1), bacteremia (1) leaking 
(1) and operator failure to accurately deploy the securement mechanism (2). 
An additional patient had a catheter removed for fever, with the catheter tip 
culture proving negative for infection. 
Discussion and Conclusions: The SecurACath system represents a novel ap-
proach to catheter securement for peripherally inserted central catheters. The 
complication profile for SecurACath PICCs in this study resembled that of 
standard PICCs. Cost savings were realized in reduced dressing materials and 
ability to forgo disposable securement systems. Clinician education and train-
ing are important in attaining accurate device deployment. Application of the 
securement system to other vascular access devices and catheters should be 
investigated in the future.
9.
ThE grEAT AnATomIc mIsconcEpTIon: ThE cEnTrAL vEnoUs 
cAThETEr Is In ThE AxILLArY vEIn, noT ThE sUBcLAvIAn vEIn
LeDonne, Jack
Greater Baltimore Medical Center, Surgery, Ellicott City, Maryland, USA
Introduction: In 2000, the author began a project to prospectively record his 
results for sonoguided “subclavian(SCV)” venipuncture. By strictly applying the 
anatomic definition of the lateral border of the 1st rib as the junction between 
the axillary(AXV) and SCV, the author soon found that he was always cannulat-
ing the AXV. SCV is never(almost never) cannulated with ultrasound. 
Method: 2660 consecutive AXV sonoguided cannulations. 
Results: 11 pneumothorax (.5%) 28 arterial punctures (1.1%) 
Discussion and conclusion: The anatomy of the human venous system has 
been accurately known for more than 300 years. When blood leaves the arm, 
it enters the AXV, then flows into the SCV and on into the brachiocephalic and 
the vena cava. When the AXV reaches the lateral border of the 1st rib, the vein 
becomes the SCV. The SCV lies in the bony tunnel bordered by the clavicle 
and 1st rib. This makes visualization of the infraclavicular SCV very difficult 
or impossible in many patients. Visualization of the SCV requires placing the 
ultrasound probe at a funny angle, which is not conducive to venipuncture. 
The SCV is taught to be an uncompromisable structure. The same factors that 
cause the SCV to be uncompressible (the bony tunnel) cause it to be difficult 
to visualize with ultrasound. In contadistinction, the AXV is easy to visualize 
and compress. Compression is one of the aids in distinguishing the AXV from 
the axillary artery.The practical ramifications of this anatomic misconception 
are: 1. The AXV is not the SCV. 2.The AXV is eminently compressible. 3. In-
tentional puncture of the AXV outside of the thoracic cage (lateral to the 2nd 
rib) will potentially lower the incidence of pneumothorax. 4. Thrombosis of 
the more central SCV may have a different clinical course, than thrombosis 
of the AXV. 5. If one were to injure the AXV (or axillary artery), the surgical 
approach is quite a bit simpler than the approach to the SCV (or subclavian 
artery), which will generally require a thoracotomy for control. 6. When the 
Centers for Disease Control (11) and the Institute for Healthcare Improve-
ment (12) issue their recommendations that the SCV is the preferred site for 
non-tunneled CVA, they are inadvertently advocating blind sticking, since the 
SCV cannot be accessed with US guidance. This goes against the large body 
of literature that supports the US-guided CVA as the safer method. The author 
regards this as an unintended consequence based on anatomic misconcep-
7.
from InTErnATIonAL gUIdELInEs To A shArEd cLInIcAL 
pAThwAY: ThE IEo pIcc TEAm ExpErIEncE 
Pari, Chiara1; Passoni, Claudia1; Di Pietro, Alessandra1; Magon, Giorgio2; 
Piredda, Alessio3; Biffi, Roberto4
1European Institute of Oncology, Melanoma Division, Milan, Italy; 2European 
Institute of Oncology, Nursing Office, Milan, Italy; 3European Institute of 
Oncology, Outpatient Department, Milan, Italy; 4European Institute of 
Oncology, Division of Abdomino-Pelvic Surgery, Milan, Italy
Introduction: “All clients requiring vascular access, regardless of duration 
of therapy, require the use of a structured approach such as an algorithm 
to facilitate a comprehensive client assessment and the development of a 
vascular access care plan prior to the initiation of therapy.” [From: Assess-
ment and device selection for vascular access. Registered Nurses Associa-
tion of Ontario 2004]. The implantation of a venous access, for therapeutic 
or diagnostic purposes, is one of the first clinical approaches to a patient. 
An evaluation of the patient means to assess the best peripheral vein to use 
and to appraise in a systematic and comprehensive way the diagnostic and 
therapeutic process the patient will have to undergo. This is important in an 
oncologic setting, where patients are followed continuatively, usually by the 
same working team, and often receive several lines of treatment. As stated by 
the National Pathway Association, the application of a clinical pathway can 
improves multidisciplinary approaches, based on guidelines and evidence 
where available for a specific patient group. This paper aims to present the 
initial application of clinical pathway methodology in a cancer center where 
a PICC team was established. 
Methods: We shared the clinical pathway with our patients to create a new 
tool: a Shared Clinical Pathway. All implants were discussed between an expert 
nurse and the patient’s physician. After reaching a consensus on the type of 
catheter to be used, the choice was routinely discussed between the nurse and 
the patient. A prospective data base was set up and all relevant information was 
reported for procedure monitoring and quality assurance evaluation. 
Results: In 18 months 70 PICCs were inserted, under US guidance, both in 
medical and surgical settings. 41 PICCs were implanted for medical care (pal-
liative or active treatments), 15 for post-surgery parenteral nutrition (TPN) 
and 1 for long-term antibiotic therapy. 12 patients were discharged with the 
device, all of them used it for both indications (TPN & chemotherapy or che-
motherapy & palliative care). 3 patients used it as a “bridge” catheter. We 
observed 3 different types of complications: 1 early removal for occlusion, 1 
deep venous thrombosis, 3 primary malpositions. 
Discussion & Conclusions: The systematic use of this Pathway improved the 
quality of life of cancer patients, since their veins were preserved and they felt 
involved in the decision-making process. This approach allowed to cut costs, 
saving time and resources and it led to a small but significant cultural change 
in a specialized cancer center with a high-case volume of central venous port 
implantation. This pathway has systematized our approach in choosing the 
best venous access among the many available. The current objective of the 
PICC team is now to design hospital-specific guidelines to choose the best 
venous access for cancer patients in different clinical situations.
8.
sEcUrAcATh sUBcUTAnEoUs sEcUrEmEnT In pErIphErALLY 
InsErTEd cEnTrAL cAThETErs: rEsULTs of A prospEcTIvE 50 
pATIEnT TrIAL wITh An InTErnAL sEcUrEmEnT dEvIcE 
Sansivero, Gail1; Siskin, Gary2; Tessier, Mary3; MacDowell, Barbara4
1Community Care Physicians, Interventional Radiology, Albany, New York, 
USA; 2Community Care Physicians, Interventional Radiology, MC 113, 
Albany, New York, USA; 3Albany Medical Center Hospital, Nursing, Albany, 
New York, USA; 4Community Care Physicians, Interventional Radiology, MC 
113, Albany, New York, USA
Introduction: 50 patients requiring vascular access with peripherally inserted 
central catheters were enrolled in this trial to test an internal securement 
mechanism. 
Methods: Both in and out patients referred to a nursing vascular access team 
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terventions to reduce infection included many innovations, a few in order of 
appearance include vigorous insertion and site care education, a swabable 
positive displacement needleless connector, chlorhexidine patch, and switch-
ing to a clear version of the same needleless connector. The VAT initiated a 
rigorous staff education program which included staff awareness and adher-
ence to proper catheter care and maintenance protocols and proper applica-
tion, defined by the device manufacturer’s instructions for use, of all devices 
which were implemented related to vascular access.
Results: There were over 13,000 central line catheter days of prospective 
surveillance per year. Rates were calculated for the Intensive Care Units, 
Medical-Surgical units, Spinal Cord Injury Unit, and Transitional Care. 
Since June 2006 the facility saw a steady reduction in CLABSIs after the 
CHG patch, increased use of PICCs, instituting clear swabable needleless 
connectors, and vigorous maintenance education of CVCs. The facility 
achieved a zero CLABSI rate in the year 2008 (p <0.05) which was main-
tained through July 2009. This is clinically significant. 
Discussion and Conclusion: The successful CLABSI reduction program 
initiated at this facility included implementation of the IHI Central 
Line Bundle along with more recently introduced interventions associ-
ated in this surveillance with a decrease in CLABSI rates. Innovations 
introduced into the facility coupled with an VAT to guide their suc-
cessful implementation, along with vigorous staff education, success-
fully sustained a zero CLABSI rate. Care and maintenance of CVCs that 
includes clear, swabable, positive displacement needleless connectors 
and a rigorous, reinforced education program on access port disinfec-
tion, catheter flushing with normal saline, daily site assessment and 
the use of a chlorhexidine impregnated disk were associated with re-
duced bloodstream infection rates. Innovations require a well planned 
educational program that includes proper device use and training in 
outstanding patient care.
tion. 7. The distance from the SCV to the cavoatrial junction is different from 
the AXV to the heart. Furthermore, I believe that since the anatomy of the 
human venous system has been completely understood for more than three 
centuries, the scientific literature must be accurate in this matter. Very little 
knowledge is handed down to succeeding generations of physicians if we 
misidentify an anatomic structure. At the heart of the matter, this is the issue: 
does anatomy matter.
10.
mAInTAInIng A zEro cEnTrAL LInE AssocIATEd BLood sTrEAm 
InfEcTIon rATE for 17 monThs Across A LArgE And dIvErsE 
AdULT pATIEnT popULATIon 
Royer, Timothy 
Nurse Driven Interventional Technologies, Tacoma, USA
Introduction: In order to improve patient outcomes and reduce costs, the 
objective of every health care facility is to achieve and maintain a zero 
Central Line Associated Blood Stream Infection (CLABSI) Rate. This facility 
achieved the goal of zero CLABSIs by applying evidence based enhance-
ments to the Central Line Bundle. These additional interventions were clini-
cally evaluated by the Vascular Access Team (VAT) which concluded signifi-
cant benefit to patient care would be realized upon their implementation. 
An essential component of this improvement program is a dedicated VAT. 
An important aspect of any improvement program is introducing innova-
tions to improve patient care in combination with vigorous, continuous staff 
education in outstanding care of the patient.
Method: Prospective surveillance and enhanced central line care has been 
implemented through a dedicated VAT for the last 6 ½ years. The team’s in-
Inception of the CLABSI Reduction Program Change in
Intervention Implemented Date Infection
PICC Insertion Team Established 1992 Rate
Formation of the Vascular Access Team (VAT) January 2003 Decrease
Implement swabable, positive displacement needleless connector January 2003 1.73 to 0.84
Implementation of the Central Line Bundle (CLB) for Insertion
Intervention Implemented Date
Hand Hygiene April 2005
Maximal Barrier Precautions upon insertion
Chlorhexidine skin antisepsis
Optimal catheter site selection and avoiding femoral in adult
Daily review of line necessity Decrease
Standardized checklist 1.01 to 0.17
Poor MD compliance with maximal sterile barrier precautions Increase
Poor nursing care and maintenance June 2006 0.17 to 1.92
Beyond the CLB - The Care and Maintenance Bundle
Intervention Implemented Date
Implement the use of chlorhexidine impregnated disk January 2006
Increase use of PICCs in place of centrally inserted CVCs Decrease
Daily review of CVC necessity and prompt removal of unnecessary lines 1.92 to 1.34
Change to the same needleless connector with clear housing January 2007
Hospital staff continuously educated on care and maintenance
Flush with 20ml of normal saline
Change needleless connector if visible signs of debris or blood Decrease
Vigorous “Scrub the Hub” connector Care and Catheter Maintenance 1.34 to 0.00
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Results: New guidelines were introduced in 4Q 2007. Due to cost constraints, 
Biopatch was used only for internal jugular and femoral sites. Incidence den-
sities of primary bacteremia are displayed in Table. According to local condi-
tion at insertion sites, dressing needed to be changed every 3 to 4 days.
2003 2004 2005 2006 2007 2008
ICU stays 2027 2041 2228 2317 2408 2448
Central venous catheter-days 7576 8272 8651 8615 9332 10145
Primary bacteremia/1000 
CVC-days*
3.3 2.3 3.0 2.7 2.4 1.4
* Significant reduction of incidence-density in 2008 « moving average charts » 
JMP7.1 
Discussion/Conclusion: The introduction of a new dressing technique, com-
bining of a chlorhexidine-impregnated sponge with a transparent occlusive 
dressing and planning for refection every 7 days for all patients with a central 
venous access in internal jugular and/or femoral site resulted in a significant 
reduction of primary bacteremia. Further generalization of use of the chlor-
hexidine impregnated device to all central venous vascular and arterial vas-
cular access may be justified on the basis of these preliminary results. These 
preliminary results strongly suggest that combined with occlusive dressings, 
the introduction of chlorexidine impregnated sponge for dressing of all cen-
tral venous catheters inserted in internal jugular and/or femoral site, signifi-
cantly reduces the rate of primary bacteremia.
13.
Iv cAnnULATIon - A focUs on fILm drEssIngs And rEdUcIng 
compLIcATIons 
Hearse, Neville
Royal Adelaide Hospital, Adelaide, Australia
Introduction: The IV insertion team collected data over an 8 month period, 
focusing on complication rates associated with cannula insertion and mainte-
nance of these devices. The data was collated into significant events affecting 
longevity of theses devices and cost impact of re-insertion, as well as film 
dressing choice for retention of these devices. A further trial is currently being 
undertaken utilising IV3000 in place of current film dressing with an expect-
ed measurable reduction in dressing related complications of approx 80%. 
Method: 5963 cannulations were captured and subsequently monitored for 
associated complications. 2521 complication s were captured and further 
broken down into the following categories: Tissued- 805 Pulled out- 474 Fell 
out- 1218 Infected site- 24 Cost of Initial Insertions, using current film dress-
ing- $1,341 AUD Cost of re-insertions using current film dressing- $2,033. 
Results: Complication rate was 42.3% of all peripheral IV lines placed with 
the major complication being dislodgement (Fell or Pulled out): 1692 com-
bined dislodgements. 805 cannula tissuing events may at times be attributed 
to poor cannula fixation. This was the first comprehensive study of cannula 
complication events within our institution and those involved in gathering and 
collating data were genuinely concerned at the complication rates captured. 
Total cost of re-insertion was greater than initial insertion, due to resources 
and equipment necessary for re-insertion. A review of the data demonstrated 
that a review of film dressings retaining cannula would be beneficial and a 
vital first step in reducing dislodgement events. 
Discussion and conclusion: A large component of cannula insertions cap-
tured, were conducted by the ‘after hours’ IV cannula team for acutely unwell 
patients, often confused and irritable. A large proportion of cannula insertions 
are also undertaken within the Emergency Department on patient admission. 
This patient group may also be acutely unwell resulting in diaphoresis or 
‘clammy’ skin, resulting in poor adhesion from current hospital film dress-
ings. A proposal to trial Smith & Nephew IV3000 was proposed and adopted. 
Research and Development suggests increased ‘breathability’ up to 13 times 
superior to current film dressing in use, improving adhesiveness of dressing, 
thus reducing dislodgement events. The trial is centred within the Emergency 
11.
vIsUALIzIng vEIns wITh nEAr-InfrArEd LIghT rEdUcEs 
UnsUccEssfUL ATTEmpTs In BLood wIThdrAwAL In chILdrEn 
Cuper, Natascha1; Verdaasdonk, Rudolf2; de Vooght, Karen3; Kalkman, Cor4; 
de Graaff, Jurgen5
1University Medical Center Utrecht, Medical Technology and Clinical 
Physics, Utrecht, Netherlands;  
2VU Medical Center, Physics and Medical Technology, Utrecht, Netherlands;  
3University Medical Center Utrecht, Dept of Clinical Chemistry and 
Haematology, Netherlands;  
4University Medical Center Utrecht, Dept of perioperative and emergency 
care, Utrecht, Netherlands;  
5University Medical Center Utrecht, Dept of perioperative and emergency 
care, Netherlands
Introduction: Intravenous access for infusion or blood withdrawal may be 
cumbersome, especially in smaller children. Multiple puncture attempts for 
gaining intravenous access are traumatic and painful for the child. To improve 
vessel puncturing, we developed a system based on infrared transillumina-
tion (the VascuLuminator) to visualize blood vessels. A feasibility study to the 
clinical use of the prototype in the procedure of blood withdrawal in children 
was conducted. 
Methods: The usefulness of the Vasculuminator during blood withdrawal in 
children of 6 years and younger was studied in 45 children and compared to 
80 children without the system at the laboratory of the outpatient clinic of a 
pediatric university hospital. Failure rate (i.e. percentage of procedures where 
more than one puncture was necessary to gain blood) was measured. Poten-
tial confounders, such as skin color and subcutaneous fat, were registered. 
The laboratory technicians were asked to rate the use of the VascuLuminator 
after each procedure as positive, neutral or negative.
Results: The prototype was able to visualize vessels in all of the patients in at 
least one of the puncture sites (hand, foot, antecubital fossa) used for blood 
withdrawal. The failure rate of the procedures performed with the VascuLumi-
nator (1/45; 2.2%) was smaller (p = .05) than in the procedures without the 
VascuLuminator (10/80; 12.5 %). There was no confounding from the mea-
sured potential confounders. In 26 of the 45 cases, the laboratory technicians 
rated the use of the VascuLuminator during the procedure positive. In none of 
the cases, the use of the VascuLuminator was rated negative. 
Conclusion: The VascuLuminator enabled visualization of relevant veins un-
derneath the skin which are otherwise not visible. The first clinical evalua-
tion showed promising results in facilitating blood withdrawal in children by 
decreasing the failure rate.
12.
rEdUcTIon of prImArY BAcTErEmIA foLLowIng ThE 
InTrodUcTIon of chLorhExIdInE-ImprEgnATEd spongEs 
comBInEd wITh TrAnspArEnT drEssIngs on cEnTrAL vEnoUs 
cAThETErs In A mIxEd IcU
Eggimann, Philippe1; Joseph, Christine1; Thévenin, Marie-José2; Bellini, 
Cristina2; Voirol, Pierre3; Revelly, Jean-Pierre1
1CHUV, Adult Critical Care, Lausanne, Switzerland; 2CHUV, Infection 
Control, Lausanne, Switzerland; 3CHUV, Central Pharmacy, Lausanne, 
Switzerland
Introduction: In our 32-beds mixed ICU, ongoing multimodal strategy tar-
geted at prevention of catheter-related infection combine education to gen-
eral measures of hygiene with specific guidelines for catheter insertion and 
dressing since several years 1. In this context, we tested the introduction of a 
chlorhexidine-impregnated sponge for catheter dressing 2. 
Material and methods: Prospective surveillance of primary bacteremia is per-
formed according to standardized definitions. New guidelines for catheter 
dressing included the combination of a chlorhexidine-impregnated sponge 
(BioPatch) with a transparent occlusive dressing (Tegaderm) with planning 
for refection every 7 days. Other elements of the preventive strategy were 
not modified (alcoholic hand-rub with overall compliance of 65 to 68%; non 
coated catheters ; maximal sterile precautions for insertion ; skin disinfection 
with alcoholic (70deg) solution of chlorhexidine (0.5%). 
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ImpAcT of A pErIphErAL InTrAvEnoUs cAnnULATIon TEAm 
Carr, Peter J1; Glynn, Ronan W2; Kropmans, Thomas3
1Health Service Executive West/National University of Ireland Galway, 
Emergency, Galway University Hospitals, Galway, IRELAND;  2National 
University of Ireland Galway, Department of Surgery, Costello Road, Galway, 
Ireland;  
3National University of Ireland Galway, Faculty of Medicine, Medical 
Informatics and Education, Comerford Medical Education Centre Clinical 
Science Institute, Galway, Ireland
Introduction: This paper is a report of a European Working Time Directive 
(EWTD) initiative to reduce non-consultant hospital doctors (NCHD’s) hours 
by piloting an intravenous (IV) nurse team. A university hospital in Ireland was 
chosen to initiate a pilot peripheral intravenous cannulation (PIVC) team, in 
order to ascertain whether cannulation insertion could be performed effec-
tively by a team of nurses.The EWTD limits the number of hours that doctors 
are allowed to work over an average week (Garvin, McLaughlin et al. 2008). 
These limitations present nurses with new opportunities, and the potential for 
role expansion. An increasing number of patients are being treated for acute 
and chronic illnesses, and subsequently will need an IV device at some point 
during their treatment (Waitt, Waitt et al. 2004; Camp-Sorrell 2007). It has 
been previously demonstrated that the use of trained specialists in performing 
this function can improve accuracy rates, and reduce pain and distress for 
patients (Dougherty 2008). 
Methods: A team of Registered General Nurses (RGNs) (n=4), led by a 
senior phlebotomist provided PIVC. Request books were placed on each 
ward and data was recorded prior to, and after, each insertion. Informa-
tion recorded in the request sheet included patient details and ward loca-
tion, consultant and specialty, time requested, reason for PIVC, and reason 
for change of cannulae. Detailed analysis was performed on a speciality 
ward request book. Prospective descriptive statistics were employed using 
statistical software packages MAKESENS and SPSS (statisical package for 
social sciences).
Results: A Mann-Kendall trend test statistic was calculated. This value was 
statistically significant (p-value <0.05) indicating the presence of an increas-
ing monotonic (constantly increasing) trend in the percentage of first-time 
cannulation with a 98% success rate in first-time insertions at the end of 5 
months of the pilot scheme. Consistent improvement is demonstrated over 
the study period. Detailed analysis of ninety nine requests on an orthopae-
dic ward revealed that ninety six (92.3%) of the cannulae inserted were 22 
gauge; 2 cannulae were 20 gauge, and 1 cannula was 18 gauge in size. Of 
99 cannulae inserted, 82 cannulae (82.8%) of PIVC were inserted in the back 
of the hand region. 9 (9.1%) were inserted in the ante cubital fossa, and 7 
(7.1%) were inserted in the region between the ante cubital fossa and the 
wrist. Site of insertion and gauge size of the cannula are in accordance with 
best practice guidelines.
Conclusions: IV teams performing PIVC can effectively reduce insertion rate 
attempts, and potentially offer a solution to the current manpower issues aris-
ing as a result of implementation of the EWTD. A critical review of studies on 
cannulae size revealed an infection increase when larger size cannulae were 
inserted (Tagalakis, Kahn et al. 2002). A team approach to PIVC insertion and 
management can become the standard for large hospitals.
16.
rEgIsTErEd profEssIonAL nUrsEs pLAcIng cEnTrAL vAscULAr 
AccEss cAThETErs vIA ThE InTErnAL JUgULAr vEIn AT ThE 
BEdsIdE: onE YEAr EvALUATIon of A pILoT progrAm
Sansivero, Gail1; Galloway, Margy2
1Community Care Physicians, Interventional Radiology, Albany, New York, 
USA; 2St. Luke’s Hospital, Lee’s Summitt, Missouri, USA
Introduction: This program was designed to demonstrate the accuracy and 
effectiveness of a program for registered professional nurses (RPNs) to place 
central vascular access devices via the internal jugular vein at the bedside. 
Method: A retrospective review of clinical outcomes after central vascular 
Department and all patients receiving cannulations will be followed through 
admission to assess ongoing cannula placement and record episodes of dis-
lodgement, tissuing and infection events. As discussed, an expectation of 
80% improvement in dressing related complications is expected and will be 
reported on at WoCoVa conference in June 2010.
14.
vEnoUs InTErnATIonAL cLAssIfIcATIon: vIA proJEcT: sTUdY for 
ThE vALIdATIon of A cLAssIfIcATIon of ThE pErIphErAL vEnoUs 
sYsTEm wITh prognosTIc vALUE And UsEfULnEss In pATIEnTs 
UndEr InTrAvEnoUs ThErApY 
De La Torre Montero, Julio Cesar1; Montealegre Sanz, Maria2; Marcos Cac-
eres, Esther3; Alonso Vidal, Rosa Isabel3; Valles Andres, Jesus3; Moreno Ro-
driguez, Rosa Maria3; Lopez Pardo, Carmen Carlota3; Vidal Comas, Miguel 
Angel3; Hernandez Anton, Pablo3; Muñoz Jimenez, Daniel3; Rodriguez 
Portugues, Carmen3; Gomez Solana, Paloma3; Seoane Estevez, Carmen3
1Hospital Clinico San Carlos, Medical Oncology, Profesor Martin Lagos Sn, 
28040, Madrid, Spain; 2Hospital Clinico San Carlos, Medical Oncology, 
Spain; 3Hospital Clinico San Carlos, Spain
Introduction: In the diagnostic and therapeutic processes of many dis-
eases and of acute and chronic processes, the intravenous route is the 
first election for the boarding of the patient. The knowledge of the 
venous peripheral system on the part of the professionals of the health 
goes beyond the anatomical location in the moment of the boarding 
for the channeling of a catheter or the puncture for an extraction of 
blood. Aims: 1. Establish in every patient and in a temporary point a 
categorization of venous peripheral system across the measurement 
of a few parameters of observation. 2. Validate the grading scale pro-
posed venous five degrees. 3. Correlate with the proposed scale ultra-
sound evaluation of peripheral venous system. 
Methods: Single centre, observational, open, non aleatorized. We ap-
preciated best possible puncture in the veins of the arm, forearm and 
back of the hand, the possibility of channeling of different sizes of 
catheters, the perceived risk of extravasation, and the presence or ab-
sence of venous phlebitis and other injuries. We perform ultrasound 
study of the veins. The five grades proposed are: GRADE I: Full venous 
system. At least 6 optimal puncture in one of the dorsal veins of the 
hand, forearm, cephalic and basilic easily to channel large catheters, 
at least 18 G. Extravasation risk (ER): remote. GRADE II: At least 4 op-
timal puncture in one of the dorsal veins of the hand, forearm Cephalic 
and Basilic low difficulty for the channeling of large catheters, at least 
20 G. ER: possible. GRADE III: At least 2 optimal puncture in one of 
the dorsal veins of the hand, forearm, Cephalic and Basilic, difficulty 
channeling fine gauge catheters (22-24 G), the possibility of channel-
ing caliber catheters (> 20 G). Tendency to phlebitis after intravenous 
treatments (IT). ER: low. GRADE IV: At least 1 optimal puncture site 
in one of the dorsal veins of the hand, forearm, cephalic and basilica 
high difficulty for channeling fine gauge catheters (24 G and below), 
phlebitis after IT, blood samples difficulty. ER: high. GRADE V: No 
optimal puncture site in one of the dorsal veins of the hand, forearm, 
cephalic and basilic, inability to channel fine gauge catheters (24 G 
and below), phlebitis after IT, high difficulty for blood samples. ER: 
very high. 
Results: From 2009 Feb. until 2010 April we performed 174 VIA I 
Project independent assessments, and we have started and made ini-
tial ratings VIA II and VIA III, with ultrasound studies. The degree of 
coherence of Kendall’s W is 0,833, with a statistical significance p< 
0.001. The overall Kappa index for grades tested is 0.7370, with a CI 
of 95%. 
Conclusions: Significant findings at ultrasound size of the veins de-
pend on the classification given. We need to perform more surveys to 
get a validation of the proposed optimal scale, but we can affirm that 
we are in a good way to get it. Once a time the uses of a scale to the 
venous peripheral system classify can we choose the best venous ac-
cess option for the patient.
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hArmonIzATIon of porT hAndLIng: ovErvIEw of A TrAInIng KIT 
 
Desmazes-Dufeu, N.1; Nadaud, M.-J.2; Fichot, N.3; Jugie, M.3; Kriegel, I.4; 
Albert, O.5; Villiers, S.5; Douard, M.-C.5; Desruennes, E.6; Boutelier, C.7; 
Delaruelle, V.8; Miegeville, M.9; Dupont, C.10
1Cochin Hospital, Pneumology, France; 2Cochin Hospital, France; 3St 
Vincent de Paul hospital, France; 4Curie institute, France; 5St Louis hospital, 
France; 6Gustave Roussy institute, France; 7Paul Brousse hospital, France; 
8Pitié Salpétrière hospital, France; 9Louis Mourier hospital, France; 10Cochin 
Hospital, Pneumology, Paris, France
Introduction: The use of Ports is very common (chemotherapy, antibiotics, ...) 
in France. In 2000, national guidelines were published to reduce the occur-
rence of Port complications. Despite those guidelines protocols, practices, 
and complications rate are highly variable from one hospital to another. We 
considered essential to update those guidelines and improve their dissemina-
tion to harmonize practices in” Ile-de-France”.
Methods: A multidisciplinary working group of practitioners and experts in the 
field of Ports (nurses, managers, physicians, surgeons, hygienists, pharmacists, 
manufacturers of medical devices and communication professionals) met in 
2004. The group focus its work on information about Port handlings. Safety, 
efficiency, ergonomics care, patient comfort, economic constraints were part 
of reflection. So the group created a training kit about Ports handlings and 
maintenance. This kit contains a small poster to stick in the nurse office and a 
slideshow to argue poster’s information and help its dissemination. Practical 
tool with many photos, the poster is about the handlings (IV line’s connec-
tion, Huber needle insertion, dressing management, respect of closed system, 
flushing method, needle withdrawal, blood sampling’s possibility), Port main-
tenance (IV line, dressing and needle’s replacement frequency), traceability, 
good working indicators and complications management (extravasation, Port 
or catheter blockage, use of Urokinase). 
Results: Impact on nurses Port knowledge was evaluated before and 4 months 
after poster sticking (29 interviews). Knowledge improvement was observed. 
Poster content evolved since October 2004 and was finally ratified by the “Ile 
de France” hygienic committee in January 2007.
Conclusion: Tested by many nurses in and out hospital, these 2 tools are very 
useful and popular now. This work has also shown: - specialized IV team 
(physicians, nurses, …) experience and multidisciplinary reflection are im-
portant to create appropriate tools - Dissemination of information requires 
time and knowledge - Lack of status for IV teams in France has been a restric-
tion for the validation and dissemination of our work
19.
woUnd hEALIng And oThErs compLIcATIons foLLowIng 
cEnTrAL vEnoUs pLAcEmEnT In pATIEnTs TrEATEd wITh 
BEvAcIzUmAB: A sIngLE-cEnTEr, ThrEE- YEAr ExpErIEncE wITh A 
sErIEs of 336 pATIEnTs 
 
Kriegel, Irene1; Kirov, Krassen2; Marcou, Aurore2; Guillaume, Alain2; 
Ghimouz, Mourad2; Goater, Philippe2; Esteve, Marc2
1Institut Curie, Paris, France; 2Institut Curie, France
Purpose: To determine the incidence of wound dehiscence or failure to heal 
after port placement in patients receiving Bevacizumab therapy, to precise 
the best interval between port insertion and Bevacizumab administration to 
reduce the risk, to determine other side effects of Bevacizumab (thrombosis, 
skin necrosis in patients with skin metastases). 
Materials and methods: Medical records of 336 patients (266 breast cancer) 
who were treated with Bevacizumab from January 2007 through December 
2009 were reviewed. All these patients except 22 underwent port insertion 
in our institution. 14 patients underwent explant-reinsertion during Bevaci-
zumab therapy. Data analyzed included patients demographics, indication 
for port removal, schedule of Bevacizumab therapy, and other complications 
during Bevacizumab therapy. A continuous survey recording exists. 4196 
ports were inserted during the same period to patients who were not treated 
with Bevacizumab. 
access device (VAD) placement by RPNS was performed. All RPNs evalu-
ated had significant experience in ultrasound guided PICC placement and 
were educated in central VAD placement using an internal jugular vein 
approach. The educational program consisted of didactic lectures followed 
by a clinical mentoring program. 
Results: 12 RPNs participated in this program and placed a minimum of 10 
non-tunneled, non-cuffed central VADs under the supervision of an inter-
ventional radiologist. 129 patients were referred for central VAD placement 
during the first year of the program. 123/129 (95.3%) were placed success-
fully at the bedside using ultrasound guidance via the internal jugular vein. 
Complications during device placement included tip malposition (n=2), 
and inadvertant carotid artery puncture (n=1). 108/123 VADs (91.1%) were 
removed at the completion of therapy, while 11/123 (8.9%) were removed 
for reasons including the need for a more permanent device and accidental 
withdrawal. There were no device related infections or thrombotic compli-
cations. During the first year of this program, referrals to interventional ra-
diology for non-tunneled central VAD placement decreased by 40% during 
the week and by 60% on the weekend. The delay from the identification of 
need for vascular access to device placement was decreased from a mean 
of 96 hours to < 12 hours. 
Discussion & Conclusion: Central VAD placement via the internal jugular 
vein by RPNs who have undergone a focused educational program is safe and 
effective. Further education and monitoring will be required if the practice 
is to be expanded. The collaboration between interventional radiology and 
nursing has resulted in standardization of practice for site care and patient 
assessment.
17.
ThE nUrsIng roLE In cEnTrAL vEnoUs cAnnULATIon: 
ImpLIcATIons for prAcTIcE poLIcY And rEsEArch 
 
Spencer, Tim1; Alexandrou, Evan2; Frost, Steve3; Parr, Michael4; Davidson, 
Patricia5; Hillman, Kenneth6
1Liverpool Health Service, Dept of Intensive Care, Liverpool, Australia; 
2Liverpool Health Service, Australia; 3University Of Western Sydney, 
Australia; 4Dept Of Intensive Care, Australia; 5Curtin University Of 
Technology, Australia; 6University Of New South Wales, Australia
Aims and objectives: The aim of this article is to review published studies 
about central vein cannulation in order to identify implications for policy, 
practice and research within an advanced practice nursing role. 
Design: Modified integrative literature review Methods: Searches of the elec-
tronic databases: Cumulative Index of Nursing and Allied Health Literature 
(CINAHL); Medline, Embase, and the World Wide Web were undertaken us-
ing MeSH key words. Hand searching for relevant articles was also undertak-
en. All studies relating to the nurses role inserting central venous cannulae in 
adults populations met the search criteria and were reviewed by three authors 
using a critical appraisal tool. 
Results: Ten studies met the inclusion criteria for the review, all reported data 
were from the United Kingdom. There were disparate models of service de-
livery and study populations and the studies were predominantly non experi-
mental in design. The results of this review need to be considered within the 
methodological caveats associated with this approach. The studies identified 
did not demonstrate differences in rates of adverse events between a special-
ist nurse and a medical officer. 
Conclusions: There were only a small number of studies found in the 
literature review and the limited availability of clinical outcome data 
precluded formal analysis from being generated. Relevance to clinical 
practice: Central vein cannulation is potentially an emerging practice 
area with important considerations for policy practice and research. 
Training specialist nurses to provide such a service may facilitate stan-
dardising of practice and improving surveillance of lines, and possibly 
improve the training and accreditation process for CVC insertions for 
junior medical officers. For this to occur, there is a need to undertake 
well-conducted clinical studies to clearly document the value and ef-
ficacy of this advanced practice nursing role.
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EmoTIonAL proBLEm In pATIEnTs wITh ToTALLY ImpLAnTEd 
cEnTrAL vEnoUs AccEss 
Mussa, Baudolino1; Torta, Riccardo2; Binaschi, Luca2; Varetto, Antonella2; 
Castelli, Lorys2; Garrino, Cristina2; Palumbo, Anna2
1Università degli Studi di Torino, Turin, Italy; 
2University of Turin, Italy
Purpose: The use of PORT is now considered a common practice in oncol-
ogy, for continuous infusion schedules, best supportive care or when periph-
eral venous integrity is compromised. The aim of this study is to evaluate 
emotional implication of this clinical practise in a homogeneous oncologic 
population receiving chemotherapy for advanced disease of gastrointestinal 
apparatus. 
Patients and methods: 32 subject, with a mean age of 59.9 yrs (15 men, 17 
women) affected by gastroenteric tract cancer and with the implant of a PORT 
for a minimum time of 12 months were evaluated with the following instru-
ments: Hospital Anxiety and Depression Scale (HADS), EORTC QLQ C30, 
Visual Analogue Scale for the measurement of their satisfaction about cares 
(VAS), Mini Mental Adjustment to Cancer (Mini MAC) to investigate the pa-
tients’ coping style, semi-structured interview on the PORT acceptance de-
gree and possible changes of adaptations occurred in some daily habits after 
at least 12 months from the system implantation. 
Results: 3 patients out of 32 were lost for follow-up (drop out). Results of HADS 
scale evidenced a high level of anxiety and a sub-threshold level of depression; 
EORTC and VAS scales showed a subjective good quality of life level; Mini 
MAC scores suggest an extensive use of negation coping strategies. 
Conclusions: in our population levels of anxiety and depression are accord-
ing to literature data. However, a lot of patients demonstrate anxiety and 
depression scores near pathological ranges and these patients are in a higher 
risk for development of a clinical depression/anxiety. The presence of PORT is 
related with a major “medical presence” in the life of patients, with a relevant 
risk of dependency anguish (from both doctor and disease) but is not signifi-
cantly related with lifestyle limitations, as sleeping and self-care. PORT is a 
useful tool for oncologic patients and sanitary operator, in terms of safety and 
comfort, but every aspects of its employment has to be carefully examined 
(biological, emotional and psychological) for real “global approach” to the 
neoplastic patients
22.
sIngLE-cEnTEr, fIvE- YEAr ExpErIEncE wITh 168 pLEUrAL 
ImpLAnTABLE porTs In ThE oUTpATIEnT mAnAgEmEnT of 
rEcUrrEnT mALIgnAnT pLEUrAL EffUsIon 
Kriegel, Irene1; Kriegel, Irene2; Daniel, Catherine3; Marcou, Aurore3; Esteve, 
Marc3; Livartowski, Alain3; Benarab, Smina3
1Institut Curie, Paris, France; 2Institut Curie, France; 3Institut Curie, France
Purpose: Malignant pleural effusion (MPE) has a very poor prognosis, raises 
problems of medical management and impairs quality of life. The authors 
report their experience of a pleural implantable port for the treatment of re-
current symptomatic MPE. 
Description: Prospective follow-up of 137 patients between 20/8/2005 and 
1/01/2010 in a single center. 168 pleural implantable access system were 
placed in 137 patients (100 patients with breast cancers) (26 bilateral place-
ments, three cases of replacement and two ipsi-lateral placements) under se-
dation following the decision of a multidisciplinary meeting. Mean age was 
62 (range 16-92) years. Evaluation: No placement failures were observed in 
this series and no procedure-related morbidity. All patients except three ob-
tained partial or complete relief of their dyspnea. 12 patients (16 ports) were 
lost to follow-up at the time of placement. 56 of the 125 other patients (44 %) 
were receiving chemotherapy. 46 patients (36.8 %) underwent pleurodesis 
after a maximum of 2 months. 26 patients (20.8 %) died during the first 30 
days, 14 in a palliative care unit without returning home. 36 patients survived 
more than 6 months. 71 patients (58 with breast cancer (81 %)) survived more 
than 2 months, 36 with pleurodesis, 35 without pleurodesis and iterative tho-
racentesis. 30 of the 36 (83 %) and 23 of the 35 (65 %) were receiving che-
Results: 328 ports were evaluated (172 by internal jugular vein, 154 by 
sub-clavian vein and 4 by femoral vein). 3 patients were lost to follow-up. 
13 of 328 ports (4%) were associated with wound dehiscence requiring 
port removal. All dehiscences except one required port removal. The in-
terval between Bevacizumab dosing and port placement in patients with 
dehiscence was always within 7 days of port insertion. 150 ports were 
inserted in the week before Bevacizumab administration. When Bevaci-
zumab was given within 7 days of port placement, the absolute risk of 
port removal for a wound healing complication was 8.6 % (13/150). The 
absolute risk is the same from 0 to 7 days. 5 of 13 dehiscences developed 
local infection and local and general infection for one case ( 4 S. aureus 
meti S, 1 S. Lugdunensis). There were 8 dehiscences in patients who did 
not receive Bevacizumab therapy: 8/4196 (0.19 %) (fisher test: p<0.001). 
Others indications for removal included : completion of treatment in 3 
(0.91 %, thrombosis in 5 (1.5 %), other mechanical problem in 6 (1,8%), 
local infection without dehiscence in 1 (0.31 %). Thrombosis were diag-
nosed at 2 month1/2, 3 month, 5 month, 7 month and 22 month of the 
port insertion and Bevacizumab administration. There were 51 thrombosis 
in patients who did not receive Bevacizumab therapy: 51/4196 (1.2 %) 
(Fisher test p=0.43). 28 of 51 were treated without port removal. 9 patients 
with advanced breast cancer presenting skin metastases developed ex-
tensive and durable skin necrosis despite early stopping of Bevacizumab 
therapy and intensive skin care in a specialized unit. 
Conclusion: Patients receiving Bevacizumab within 7 days of port placement 
had a high incidence of wound dehiscence and port removal. The risk of 
thrombosis is not higher. We have to keep in mind the very serious cutaneous 
side effect when choosing the insertion site to a breast cancer patient with 
skin metastases.
20.
prospEcTIvE cLInIcAL EvALUATIon of A sAfETY hUBEr nEEdLE 
poLYpErf sAfE In cAncEr pATIEnTs 
 
Goossens, Godelieve A.1; Moons, Philip2; Jérôme, Martine1; Stas, Marguerite1
1University Hospitals Leuven, Oncological Surgery, Leuven, Belgium; 
2Katholieke Universiteit Leuven, Center for Health Services and Nursing 
Research, Leuven, Belgium
Introduction: Totally implantable central venous access devices (TIVADs) are 
widely used for intravenous therapy in cancer populations. By withdrawal of 
the Huber needle, the non-dominant hand is vulnerable to a ‘rebound’ stick. 
The PolyPerf Safe (PS) Huber needle (Laboratoires Pérouse, Ivry-le-Temple, 
France) is developed to increase safe use by health care professionals. We 
conducted a study to evaluate the safety and user-friendliness by end-users. 
Methods: A prospective descriptive study carried out at the University Hos-
pitals Leuven (Belgium). Five hundred PS needles were evaluated on an in-
dividual basis in cancer patients. Different aspects of the PS were assessed: 
packaging, needle insertion and needle removal. Nurses indicated if they 
inserted or removed the needle for the first time or not. Comparison with the 
standard Gripper® needle was assessed only in terms of ‘safety’ and ‘ease of 
use and training’. 
Results: Three hundred sixty-six forms were analysed. No statistical difference 
was found between first and non-first users. Packaging and access evaluations 
were scored in general positively except for two aspects: (1) needle stability 
and (2) ease of dressing. The ‘ease of removal’ was scored unsatisfactory in up 
to 22.4% of the registrations. Pain at insertion was recorded in about one in 
five registrations and blood contact in 2.5% of non-first users. The safety as-
pect was scored good however the ‘ease in use’ and ‘ease in training’ scored 
in 25.4 to 43.8% less than the Gripper®. 
Discussion and conclusions: Nurses evaluated the PS in general positively 
with exception of ‘needle stability’; ‘ease of dressing’ and ‘ease of removal’. 
No needlestick accidents were recorded. Aspects of ‘ease in use’ and ‘ease 
of training’ scored less compared to the Gripper® in up to one-third of the 
registrations.
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single use of the catheter were assessed. 
Method: At a university teaching hospital 10 patients received a double lu-
men port catheter (5 men, 5 women; mean age 61.5 ± 12 years). In all cases, 
both chemotherapy and PN were indicated. All port implantations were per-
formed under ultrasonographic and fluoroscopic guidance in the radiological 
interventional suite. Procedure related immediate, early, and late complica-
tions were recorded until removal of the device, patient’s death or reached 
follow-up period. 
Results: No immediate complications were observed. First use of the port 
system for chemotherapy was within 12 d (± 25 d, range 0 - 84 d) and within 
17 h (± 22 h, range 0 h - 72 h) for PN on average. During the application of 
PN no delay or interruption of the chemotherapeutic treatment was observed. 
The port catheter was used for the simultaneous application of chemotherapy 
and PN for a total of 1216 h. The time-ratio for simultaneous use to single 
use was 1:17.21 h. One port catheter had to be removed after 30 days due 
to port infection.
Discussion and Conclusion: Central venous double lumen port systems can 
offer the best patient care for simultaneous chemotherapy and parenteral nu-
trition with a low complication rate.
25.
prospEcTIvE sTUdY on sATIsfAcTIon And qUALITY of LIfE 
of oncoLogIcAL pATIEnTs hAvIng BEnEfIcIATE of ToTALLY 
ImpLAnTABLE vEnoUs AccEss dEvIcE pLAcEmEnT 
Liberale, Gabriel1; Lecocq, Celine1; Rwigemera, Allan1; Boutros, Giad1; 
Bouazza, Fikri1; Fernez, Brigitte2; Moreau, Michel3; Toussaint, Emmanuel4; 
El Nakadi, Issam1
1Institut J. Bordet (Ulb), Surgical Oncology, Brussels, Belgium; 2Institut 
J. Bordet (Ulb), Brussels, Belgium; 3Institut J. Bordet (Ulb), Statistic 
Department, Brussels, Belgium; 4Institut J. Bordet (Ulb), Medical Oncology, 
Brussels, Belgium
Introduction: Totally implantable venous access devices (TIVAD) are easy and 
safe systems for infusion of chemotherapy in patients with cancer. The easi-
ness of use and the guarantee of the preservation of the quality of life (QoL) 
make it the reference for the long-term venous access although poor data are 
reported in the literature about the QoL of patients who underwent TIVAD 
placement. The aims of this study were to evaluate the satisfaction and the 
QoL of oncological patients having beneficiate of TIVAD placement. 
Method: Prospective study including exclusively oncological patients who 
underwent TIVAD placement under local anaesthesia. The questionnaire 
used was derived from the QoL EORTC questionnaire. The questionnaire was 
anonymous and evaluate the esthetical satisfaction (scar aspect and position), 
the pain during and after TIVAD placement, information before and during 
TIVAD placement and various aspect of the impact on daily life (discomfort, 
port position,…). Chi square tests were used for statistical analysis (indepen-
dance of qualitative value). 
Results: 289 patients participated to this study. There were 232 F (80%) and 
57 M (20%). 92 % of patients had no or little discomfort; 87,6% had no or 
little pain; 76,33% were very satisfy or satisfy by the port location; 89,32% 
were very satisfy or satisfy by scar location; 72,60 were very satisfy or satisfy 
by the esthetical results; 24,55% felt pain or pain more than expect. Preopera-
tive information and intraoperative information were respectively excellent or 
satisfactory in 72,64% and 75,91%. Immediate pain was higher in patients 
<45y (p<0,0154), in patients with insufficient pre/intra-operative informa-
tion (p<0,0001) and in female(p<0,0001). Late postoperative pain (>1w) was 
higher in patients<45y (p<0,0008), in patients with insufficient pre-op infor-
mation (p<0,0002) and in female (p<0,0383). Discomfort were higher in pa-
tients with insufficient information (pre/intra-operative). Esthetical satisfaction 
were lesser in patients <45y (p<0,0203) and in patients with insufficient pre/
intra-operative information (p<0,0003). 
Conclusions: Pre-operative information has a major impact on the intra/post-
operative pain, discomfort and esthetical results. Female of <45y are more 
sensitive to scar location, port location and esthetical results.
motherapy. The overall median survival time was 180 days in the group with-
out pleurodesis and 300 days in the group pleurodesis (p= 0.01). But, when 
adjusting with chemotherapy, the overall median survival time was 290 days 
without pleurodesis and 310 days in the group pleurodesis (p=0.045). Several 
patients developed loculation of the pleural cavity making further thoracente-
sis ineffective. Four infectious complications ( 1 infectious pneumonia , 1 skin 
infection over the puncture site, 1 catheter-related infection (E. Coli) and 1 
empyema (S. aureus)) and three mechanical complications (1 expulsion of the 
port and 2 disconnections between the port and the catheter) were observed 
and easily treated. No case of permanent obstruction was observed, and pain 
during puncture was easily avoided by anti-nociceptif agents. The diffusion 
of innovation was very quick: 5 ports and 19 thoracoscopy in 2005, 25 ports 
and 10 thoracoscopy in 2006, 25 ports and 5 thoracoscopy in 2007, 42 ports 
and 8 thoracoscopy in 2008 and 44 ports and 6 thoracoscopy in 2009.
Conclusions: The pleural implantable access system is an interesting alterna-
tive in terms of efficacy and safety for the outpatient management of malig-
nant pleural effusion. It is an alternative for difficult thoracentesis (for patients 
or for the physician). It has to be considered in all patients and probably as 
the first line treatment for patients with trapped lung, bilateral effusions and 
compressive effusion. It presents a number of advantages in terms of comfort 
and infectious risk compared to tunnelled pleural cath.
23.
ToTALLY ImpLAnTABLE vEnoUs AccEss porTs sYsTEms And rIsK 
fAcTors of compLIcATIons: A onE YEAr prospEcTIvE sTUdY In A 
cAncEr cEnTrE: 815 nEw pATIEnTs 
Jean-Laurent, Mehdi1; Narducci, Fabrice2
1University Hospital, Gynecology, Fort De France, Martinique; 2Cancer 
Centre, France
Introduction: Venous access is a concern for patients receiving prolonged 
courses of cytotoxic therapy for solid cancers. It is a common practice to 
place a Totally Implantable Access Port System in patients beginning a course 
of chemotherapy to improve venous access reliability and to avoid potential 
peripheral venous and external central venous accessing problems. However 
TIAPS is associated with a number of complications. Our aim was to access 
the risk factors of these complications. A prospective study was undertaken 
with 815 patients who needed a TIAPS.
Patients and Methods: This was a consecutive and prospective study in one 
cancer centre. Between 2nd of May 2006 and 30th of April 2007, we includ-
ed 815 patients who had a TIAPS. The placement of the TIAPS was surgical. 
The venous access were external jugular vein, cephalic vein, internal jugular 
vein, femoral vein and subclavian vein. We reported all preoperative, per and 
post operative data during one year. Results The global morbidity was 16.1% 
during one-year follow up (131/815) (Table 2). Port devices were removed 
because of complications in 55 patients (6.8%) In our study, the most signifi-
cantly predictive factor of morbidity was the time between insertion of TIAPS 
and the first use. Indeed, using TIAPS within seven days following the inser-
tion increases infection rate (17% vs 2%, p<0.001) and as a consequence 
increases the removal rate of the port (8.5% vs 4.9%, p<0.05). 
Conclusion: To decrease infection and port expulsion, we recommend re-
specting a delay of 7 days following TIAPS insertion.
24.
An oBsErvATIonAL sTUdY of cLInIcAL oUTcomEs wITh doUBLE 
LUmEn cEnTrAL vEnoUs porT sYsTEms In cAncEr pATIEnTs UsEd 
for concomITAnT AdmInIsTrATIon of chEmoThErApY And 
pArEnTErAL nUTrITIon 
Nagel, Sebastian
Charité Universitätsmedizin Berlin, Department of Radiology, Berlin, 
Germany
Introduction: To evaluate the clinical benefit of low-profile double lumen port 
catheters in patients receiving simultaneous chemotherapy and parenteral nu-
trition (PN). Advantages, complications and the time-ratio for simultaneous to 
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28.
UsE of TEsIo cAThETErs In InfAnTs And chILdrEn rEcEIvIng 
chronIc hEmodIALYsIs 
Musumeci, Antonino1; Nuzzi, Francesca2; Graziano, Ugo3; Ferraiuolo, 
Salvatore3; Severino, Giovanni3; Pecoraro, Carmine2
1University Federico II, Cardiology, Naples, Italy; 
2Santobono Children’s Hospital, Nephrology and Urology, Naples, Italy; 
3Santobono Children’s Hospital, Surgical Sciences, Naples, Italy
Introduction: Tesio Catheters (TC) were first used in adults as a dual-catheter 
system with two independent single-lumen catheters into the right internal 
jugular vein. TC have been associated with improved Qb compared with oth-
er catheter types and recirculation rates less than 5%. The recent availability 
of pediatric-sized TC has further expanded the hemodialysis catheter options 
available for children. We report the experience with TC survival rates, com-
plications and effect on dialyisis adequacy in a series of children on HD of a 
single pediatric hemodialysis center. 
Method: From January 2003 to March 2010, 43 children underwent chronic 
hemodialysis for ESRD: 21 (15 boys) of them (48.8%) received TC as cen-
tral vascular access; mean age 3.1 years; range 0.5-11.9 years. Primary renal 
diseases that caused ESRD were: Focal Segmental Glomerulo Sclerosis (6), 
Renal HypoDysplasia (6), Oto-Branchio-Renal Syndrome (1), Wolff-Hirschon 
Syndrome (1), Middle Aortic Syndrome (1), Atypical Haemolitic Uremic Syn-
drome (2), Oxalosis (1), Diffuse Mesangial Sclerosis (3). Indications for cen-
tral venous catheter use in these patients included: low body size (weight 
range: 5 to 19 Kg) (n=13); main neurological complications (n=4); need for 
daily hemodialysis (n=1); periferal venous vessel exhaustion (n=3).TC were 
inserted with ultrasound guidance into the right internal jugular vein on gen-
eral anesthesia by vascular surgeon in our institution. 
Results: Four patients received a single TC-10,5 F, in them hemodialysis was 
performed with a double alternate blood pump; in the remaining 17 patients 
twin single lumen TC 6.5 F and 10 F, in 15 and in 2 patients respectively, were 
inserted. Only in one case a mild right pleural effusion developed as com-
plication. Until now 26 interventions in 21 children have been performed: 
5 patients needed of removal with replacement of TC because of a) increase 
of body height with relative shortness of TC (n=2); failure because of throm-
bosis (n=2); dialysis inadequacy (n=1). Our procedure for the management 
of TC includes disinfection of the exit site weekly, oral warfarin and in situ 
urokinase and heparine to maintain lumen patency, without side effects. No 
episode of TC and/or tunnel and/or exit site sepsis occurred over 23 months 
mean follow up (range: 3-82 months). Monthly single poolKt/V was > 1.5 
in all patients indicating adequate dialysis. Due to lack of pain related to 
venipuncture and the confidence in one’s movements, patient and parents 
compliance was very good.
Discussion and Conclusion: Use of TC in children on chronic HD is very 
limited, our excellent experience also in children weighing less than 10 Kg 
is unique. We conclude that TC are a reliable, effective in term of dialysis 
adequacy and low infection long term vascular acces in infants too.
29.
vAscULAr AccEss profEssIonAL orgAnIzATIons: A mULTI-
dIscIpLInArY ApproAch 
Bowe-Geddes, Leigh Ann; Haylock, Pamela J.
Association for Vascular Access, Herriman, UT, USA
The traditional role of healthcare professional organizations is to advocate 
on behalf of the profession, individual members, and the patient population 
being served. Benefits to members include professional and educational re-
sources, introduction to emerging information and technologies, and oppor-
tunities to meet, communicate with, and learn from colleagues with similar 
interests. Throughout its 25 year history, the Association for Vascular Access 
has been and remains unique among healthcare professional organizations: 
it is first and foremost, a multidisciplinary membership – comprised of physi-
cians, nurses, pharmacists, radiology technicians, researchers, engineers, and 
industry professionals, among others. AVA maintains collaborative partner-
ships with industry, fostering research, invention, innovation, application of 
26.
BrAchIAL ArTErY-JUgULAr vEIn JUmp grAfT: A sALvAgE 
procEdUrE for vAscULAr AccEss 
Shirvani, Amir1; Kalantar Motamedi, Ali Reza2
1Iran University of Medical Science, Tehran, Iran, Islamic Republic Of;  
2Iran University of Medical Science, Iran, Islamic Republic Of
Introduction: Stenosis or chronic occlusion of the axillary or subclavian vein 
is a problem with a difficult solution in patients in whom a permanent vas-
cular access is mandatory for hemodialysis. In such a situation and on other 
occasions such as failure of multiple previously placed fistulas, arm and ce-
phalic vein exhaustion due to multiple fistula placement or thrombosis, and 
severe congenital upper limb hypoplasia we used the external or internal 
jugular vein for venous drainage, a procedure using PTFE grafts to connect the 
brachial artery to the external or internal jugular vein under local or regional 
anesthesia. 
Method: A prospective analysis was made on 11 patients who received a 
brachial artery-external/internal jugular Polytetrafluoroethylene (PTFE) jump 
graft for hemodialysis access. The procedure was chosen due to exhaustion 
of the veins in the upper extremity because of previous multiple failed fistu-
las or grafts. Results: In 2 patients the procedure failed after several months. 
6 patients retained functioning grafts for more than 18 months after shunt 
construction. 3 patients are still under observation and they have a functional 
graft after 3 months.
Discussion & Conclusion: We believe that the brachial artery- external/in-
ternal jugular vein jump graft is a salvage procedure that can be used for 
vascular access when all upper extremity veins including the subclavian or 
axillary veins cannot be used.
27.
rELATIonshIp BETwEEn vEssEL dIAmETEr And TImE To 
mATUrATIon of ArTErIovEnoUs fIsTULA for hEmodIALYsIs 
AccEss 
Khavanin Zadeh, Morteza1; Danandehpour, Sarah2; Naderpour, Zeinab3
1Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, 
Iran, Islamic Republic of;  
2Iran University Of Medical Sciences, Tehran, Iran, Islamic Republic of;  
3Emam Khomeini Hospital, Tehran, Iran, Islamic Republic of
Introduction: Dialysis Outcomes Quality Initiative Clinical Practice Guide-
lines, sponsored by the National Kidney Foundation, reflect general consen-
sus that native arteriovenous fistulas (AVF) represent best vascular access. The 
objective of this study was to determine the correlation between diameter and 
maturation of vessels in radiocephalic AVF. 
Patient and Methods: In this cross-sectional study, 96 hemodialysis patients 
from Hasheminejad Kidney Center participated and all of them had radio-
cephalic AVF. We completed the data collection form for each; we collected 
data about their vein and artery diameter, and time to fistula maturation ac-
cording to their records. Results: The mean of age was 54.70 (SD=17.17) 
years. Mean artery diameter was 2.57 (SD=1.09) mm. Mean vein diam-
eter was 2.40 (AD=0.79) mm. Also the mean maturation period was 38.60 
(SD=42.13) days. In this study, vein diameter was correlated with maturation 
period of radiocephalic fistula (P=0.04). 
Conclusions: According to our data the vein diameter is correlated with matu-
ration of fistula, but no correlation was seen with diameter of the arteries. 
There is much discrepancy between times to maturation in various reports. 
In a metanalysis article the average time for fistula maturation is reported to 
be 2-3 months but in our study, it was 38/6 days. In some other surveys there 
was a direct relation between maturation of fistula with both age and gender. 
This was not seen in our study. Future studies should be performed with more 
samples to evaluate these factors and also other factors which can decreases 
the period of fistula maturation.
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between the types of CVCs. • 93.3 % would use this specific educational 
website dedicated to improving patient safety. The initial CVC education was 
provided by the Vascular Access Nurses (VAS). Second quarter comparison of 
random CVC reports generated, detailing the unit nurse’s identification of the 
patient’s CVC with the VAS nurse’s identification of the same CVC, revealed a 
100% accuracy rate. Ongoing monitoring of staff behaviors leads to a down-
ward trend of CVC infections as evidenced by a 0% PICC infection rate for 
2010 and 100% compliance of VAS nurses utilizing a central line checklist 
with PICC insertions.
31.
cEnTrAL vEnoUs cAThETEr InsErTIon BY cLInIcAL nUrsE 
consULTAnT or AnAEsThETIc mEdIcAL sTAff: A sIngLE cEnTrE 
oBsErvATIonAL sTUdY 
Yacopetti, Nicholas1; Alexandrou, Evan2; Spencer, Tim3; Frost, Steve4; David-
son, Patricia5; O’Sullivan, Greg6; Hillman, Kenneth7
1St Vincents Hospital, Australia; 2University of Western Sydney, Australia; 
3Liverpool Health Service, Australia; 4University of Western Sydney, Australia; 
5Curtin University of Technology, Australia; 6St Vincents Hospital, Australia; 
7University of New South Wales, Australia
Objective: To compare clinical outcomes of elective central venous catheter 
(CVC) insertions performed by either a clinical nurse consultant (CNC) or 
anaesthetic medical staff (AMS). 
Design: Prospective audit of a convenience sample for consecutive CVC in-
sertions from July 2005 to October 2007. Setting: Metropolitan University 
affiliated hospital providing acute, chronic and outpatient services. Partici-
pants: Out-patients and inpatients requiring a CVC for both acute and chronic 
conditions. Main Outcome Measures: Number of CVC lines inserted, patient 
groups, complications during and after insertion. 
Results: There were 245 CVCs inserted by AMS and 123 by the CNC over a 
28 month period. The most common indications for CVC placement in both 
groups were for the treatment of oncology and autoimmune disorders (61%) 
and for antibiotic therapy (27%). Parenteral nutrition (PN) (2%), and other 
therapies (10%) accounted for other indications. There was no significant dif-
ference in complications on insertion between groups. Anaesthetic medical 
staff failed to obtain access in five attempted procedures compared to one 
by the CNC. The rate of CVCs investigated for infection was twice as high in 
the AMS group compared to those placed by the CNC (19% versus 8%).Con-
firmed catheter related blood stream infection was 2.5 per 1000 catheters in 
the AMS group and 0.4 per 1000 catheters in the CNC group (p=0.04). 
Conclusion: Both the AMS and CNC had favourable insertion outcomes. In-
fection outcomes differed between the AMS and CNC with a higher rate of 
CRBSI in the AMS group.
32.
pErIphErALLY InsErTEd cEnTrAL cAThEThErs (pIcc) In onco-
hEmAToLogIc pATIEnTs: A cEnTEr’s ExpErIEncE
Riccardo, Destefanis; Vincenzo, Matozzo; Paola, Brambilla; Fabio, Ciceri; 
Andrea, Assanelli; Consuelo, Corti
San Raffaele Hospital of Milan, Italy
Objective: To evaluate the success rate of insertion of peripherally inserted 
central catheters (PICCs) and their duration and the short- and long-term com-
plications in an onco-hematological setting. 
Study design: We started a prospective collection and analysis of the data 
of the patients who underwent PICC placement from January 2008, with a 
total of 122 PICCs insertions. A well-trained team of nurses supervised by 
medical doctors has been in charge of insertion and management of PICCs. 
Data regarding type of catheter, site of catheter placement, reason for catheter 
removal, duration of use of the catheter and the rate of complications have 
been collected. 
Results: The success rate of PICC insertion was 85%, with no acute or late 
complications. The mean duration of PICC treatment has been 54 days (range 
1±222). PICCs have been removed or not correctly inserted in 15% of the 
technology and knowledge-building to promote patient safety and comfort in 
the delivery of vascular access care and services. As the vascular access spe-
cialty continues to advance technologically and vascular access use expands 
throughout the world to high and low-resource regions, professional asso-
ciation affiliations can provide critically important assistance in knowledge 
and skills building, proper device and product selection and their safe ap-
plication. This abstract presentation provides an overview of considerations, 
strategies, challenges, and opportunities for creating and sustaining vascular 
access professional organizations in a variety of vascular access care settings. 
The multi-disciplinary approach AVA employs is advantageous, reflecting the 
multi-disciplinary team model of care provided in clinical settings, and the 
blend of professionals facilitates interdisciplinary communication. Direct ac-
cess between clinicians and industry professionals provides opportunities for 
product and service planning, development and implementation. Organiza-
tional leaders represent membership. A multi-disciplinary board of directors 
and committee structure leads AVA. Staff and the board collaborate on stra-
tegic planning to establish goals and formulate plans for reaching short- and 
long-term goals. Board agendas and committee activities are based upon the 
strategic plan. Despite the benefits of the multi-disciplinary structure, it also 
presents challenges. Continuing education offerings must meet educational 
needs of all disciplines, and offering discipline-specific continuing education 
credit creates financial and logistical challenges. Marketing, member recruit-
ment and benefits to varied targets are significant challenges. Vascular access 
is an essential component of acute and long-term health care in a multitude 
of settings; yet vascular access education has been traditionally minimized for 
most healthcare professionals. The opportunity exists for professional orga-
nizations specializing in vascular access to advance healthcare professional 
expertise and patient outcomes.
30.
gUIdE-wIrEd: An InTrAnET-BAsEd gUIdE To cEnTrAL vEnoUs 
cAThETEr IdEnTIfIcATIon And cArE 
Scheppske, Nina
Franklin Square Hospital Center, Vascular Access Services, Rosedale, USA
Introduction: Chart audits and routine performance improvement checks re-
vealed a need to implement education regarding central venous catheter ac-
cess devices (CVC). Nurses at our facility were able to implement evidenced-
based, best practice measures by utilizing state-of-the-art technology, current 
computer documentation process, and links to a newly created educational 
website while at the patient’s bedside. 
Method: Several of the IV Therapy leadership staff from within our multi-
hospital organization, collaborated and reached a consensus as to the extent 
of education required to provide safe patient care. Our informatics nurses 
incorporated existing software programs to create the electronic website 
framework. Nursing opinion was solicited to accurately assess their needs via 
phone, email and an anonymous on-line survey. Based upon those findings 
the intranet-based website was designed. Our corporate legal team provided 
support and direction for this project. Written copyright permission was ob-
tained from all entities solicited, including those that supply products to our 
facilities, to use photographs of their specific catheters, products and educa-
tional materials on our website entitled: Vascular Access Services and can be 
accessed at: https://teamport.medstar.net/ fshvascularaccess. 
Results: The draft TeamPort site was introduced to our hospital staff on January 
25, 2010, at the “Vascular Access Open House”, which included: emergency 
care of CVCs; flushing guidelines; infection prevention; PICC care; CHG ap-
plication; and dressing changes. Additional requests to add educational in-
formation to the website regarding peripheral IVs; pediatrics; when to use 
heparin; and priming IV pumps have been received. Within 60 days of the 
initial introduction of the draft website, a positive interest in utilizing this 
website has grown to encompass all nine hospitals within our organization as 
evidenced by a 90.47 % positive response rate from the anonymous survey. 
Conclusion: Increased best practice awareness leads to consistent identifica-
tion; and care and maintenance of central venous catheter access devices; 
contributing to a decrease in catheter related complications. The results of the 
first quarter anonymous survey revealed: • 57.5 % knew what action to take 
in the event of a central line emergency. • 74.6 % were able to differentiate 
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to determine if the time and date of the cannula insertion was recorded. 
Staff were questioned regarding observation of cannula sites for signs 
of infection and actions taken. Methodology Practice developers con-
sulted with infection control staff, nurse managers and the local drugs 
& therapeutics committee. A nurse led pilot was proposed to develop 
new documentation for the insertion and maintenance of IV cannulae 
and to research safety cannulae and existing systems in the hospital. The 
hospitals intravenous policy was reviewed concurrently. An Intravascu-
lar Device Assessment Record (IVDAR) was developed incorporating the 
RCN (2007) phlebitis and infiltration scale. Only one closed system that 
met the group criteria was found. The costing was compared with exist-
ing safety cannula and ‘add on’ needle free extension sets currently used 
within clinical areas. After comparison, an overall cost reduction was 
predicted for the hospital. The system was phased in hospital wide with 
training led out by the NPDU clinical facilitators and supported by BD 
trainers over a three months in 2009. 
Results: Multidisciplinary Education for nurses, NCHD’s medical and 
nursing students resulted in wide compliance with the IVDAR, and the 
BD ‘NEXIVA’ closed IV catheter system; however, on re-audit there were 
still some units that did not meet the compliance standards. Overall, the 
adoption of an all in one cannula and combined extension set reduced 
cost to the hospital and increased compliance with the closed system to 
85% hospital wide. The reporting rate for grade 2+ phlebitis rose how-
ever, this was regarded to be due to the utilisation of the IVDAR and 
increased reporting after education. 
Conclusion: This nurse led initiative led to SGH being the first hos-
pital in Ireland to adopt a completely closed, safety PVC system. 
The roll out of the IVDAR presented a standard for the unit to audit 
practice and to introduce PVC care bundles to clinical areas, which 
is ongoing.
35.
EvALUATIon of An EdUcATIonAL progrAmmE In 
mAnAgEmEnT And cArE of cEnTrAL vEnoUs AccEss dEvIcEs 
Troeng, Margareta
Skåne University Hospital, Sweden
Introduction: Long-term central venous access devices (CVAD), mainly 
central venous catheters (CVC) and implanted ports, are frequently used 
in patients with hematological malignancies. They are highly needed in 
order to administer chemotherapy, stemcell infusion and support thera-
py during the acute aplastic period. There is a further need in chronic 
phase. However, their use implies a serious risk of bloodstream infection 
that could become life-threatening for the neutropenic patient. Evidence 
consistently demonstrates that the risk of catheter related infection de-
clines following standardisation of aseptic care and educating staff in 
aseptic practices. The aim of the study was to evaluate an educational 
programme in management and care of CVADs by comparing adher-
ence to practices in recommended evidence-based guidelines between 
nurses that had participated in the educational programme and those 
who had not. 
Methods: Structured observations of adherence to the guidelines were 
performed using a checklist from a previous study. Specified behaviours 
of hygiene precautions, aseptic care and antisepsis were defined to be 
observed when a nurse changed a CVC dressing or accessed a port by 
inserting a needle. Observational data from 46 nurses in the educational 
group and 41 nurses in the comparison group were analyzed statisti-
cally. 
Results: The results show that the nurses who had participated in the edu-
cational programme had significantly fewer deviations (mean 0,8) from 
the recommended guidelines than the nurses who had not participated 
(mean 3,5). The deviations in the comparison group had the character of 
incomplete performance in the various behaviours. 
Conclusions: The nurses that had participated in the educational pro-
gramme carried out the procedures in close adherence to recommended 
evidence-based guidelines which in turn implies decreased risk of cath-
eter related infection.
patients, because of local bleedings for multiple vein punctures or arterial 
punctures (9% and 1% respectively) and because of mechanical occlusions 
(23%). The PICC infection has been assessed by positive blood cultures and 
its rate has been 2%. The PICC correlated vein thrombosis rate was diagnosed 
in 4 patients (8%). 
Conclusion: Our initial experience confirms that PICCs are easily inserted 
and convenient with an important vascular saving in onco-hematologic pa-
tients, in whom peripheral drip or central venous catheter insertion is not pos-
sible. The percentage of prematurely removed catheters seems acceptable, 
after a mean period of 2 months. Our data seem to suggest the need of a 
randomized trial of PICCs and conventional CVCs in hospitalized patients re-
quiring central access especially because of a growing trend in many hospital 
hematology and oncology services to switch from use of cuffed and tunnelled 
CVCs to PICCs.
33.
EsTABLIshIng A nUrsE-LEd cEnTrAL vEnoUs cAThETEr InsErTIon 
sErvIcE: A procEss EvALUATIon 
Alexandrou, Evan1; Spencer, Tim2; Frost, Steve3; Parr, Michael4; Davidson, 
Patricia5; Hillman, Kenneth6
1University of Western Sydney, Australia; 2Liverpool Health Service, Australia; 
3University of Western Sydney, Australia; 4Liverpool Health Service, Australia; 
5Curtin University of Technology; 6University of New South Wales, Australia
Background: Health care systems promote care models that deliver both safe-
ty and quality. Nurse-led vascular access teams show promise as a model to 
achieve hospital efficiencies and improve patient outcomes. 
Objectives: The aim of this paper is to discuss the process of establishing a 
nurse led central venous catheter (CVC) insertion service in a university affili-
ated hospital using a process evaluation. 
Method: Archival information, including reports, communications and min-
utes of departmental meetings were reviewed. Key stakeholders involved in 
establishing this nurse-led service at the time were interviewed. 
Results: A nurse-led CVC insertion service was first established in 1996 and 
has increased in service provision over 13 years. Initially there was scepticism 
from some medical practitioners about the feasibility of a nurse performing a 
traditional medical procedure. The service currently provides central venous 
access across the hospital including critical care areas. The service places up 
to 500+ catheters per annum. 
Conclusions: Establishing a nurse-led CVC insertion service has increased 
organisational efficiencies and provided an infrastructure for support of best 
practice. The support of senior management and medical practitioners was 
crucial to the successful implementation of this model of care.
34.
BEsT prAcTIcE – sAfE prAcTIcE “ThE fIrsT IrIsh hospITAL To 
AdopT A compLETELY cLosEd pErIphErAL vAscULAr cAThETEr 
sYsTEm” 
Scanlon, Maureen; Hannon, Charlotte
Sligo General Hospital, Ireland
This is the journey of one general hospital in Co Sligo, Ireland as the 
Nurse Practice Development Unit (NPDU) led out on a ‘Best Practice Ini-
tiative’ for management and care of Peripheral Vascular Cannulae (PVC). 
As stated by Peterson (2002) the majority of patients admitted to hospital 
will become a recipient of a vascular access device at some time, the 
staff in SGH wanted this to be the safest, least invasive, most comfort-
able experience for the shortest time possible. In 2008 nurse practice 
developers carried out a literature review of best practice initiatives for 
care of PVC and infusion fluids and an audit of the Intravenous Infusion 
Policy of the hospital: specifically 1) Documentation in use. 2) Phlebitis 
and Infiltration scoring/recording. 3) Length of time that PVC were in 
situ. 4) Reporting/Risk management practices. The audit took place in 
surgical, medical and oncology units Patients were observed to detect 
if an IV device or infusion were present. Documentation was reviewed 
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suggestion for choosing the best catheter to be used for those patients, with 
a wide variety of vascular devices which can improve the care and manage-
ment of the patient himself, his quality of life, and which may support the best 
practice for nurses and physicians. To date, the review of the literature shows 
the benefits given by ultrasound technique for the positioning of a central 
venous catheter, which can be inserted also by peripheral access, and illus-
trates how this procedure can be performed by anyone who has the specific 
know-how(2-5). Peripherally inserted central catheters and midline catheters 
could ensure a valid access for patients who are under treatment during pre 
and post-transplant period; they are also progressively becoming an alterna-
tive choice in the use of traditional tunnelled catheters, but there aren’t still 
enough data for this kind of patients in the literature. Our experience, started 
on February 2008, is ongoing to evaluate the efficacy, referring to best quality 
of life, the expected lower rate of infections and replacements of the above 
mentioned devices, and the cost-effectiveness. For this reasons we decided 
to adopt a new strategy in administrating drugs, blood and platelets trans-
fusions, parenteral nutritions, in performing blood samples both in charged 
and discharged patients, to observe if these devices give advantages in the 
management of these pediatric patients waiting for HSCT. We hope that the 
use of these devices will carry on advantages to improve care, management 
and quality of life of the patients, supposing evidences could come from easy 
availability of ultrasound technique, easy possibility to perform the insertion 
bed-side, respecting all warnings in terms of patient’s and operator’s security, 
and easy acquisition of the specific required know-how, with the aim to re-
duce waiting time for the insertion.
38.
ThE AdEqUATE IndIcATIon of A vAscULAr AccEss In ThE 
oncoLogIcAL pATIEnT
Carrero Caballero, María Carmen
Hospital Ramón y Cajal, Spain
The adequate indication of a vascular access in the oncological patient In-
troduction The oncological patient, more than any others, requires vascular 
access to be completely safe while under antineoplastic therapy. The need of 
a continuous approach to this patient vascular system, entails an important 
deterioration of his/her venous anatomy, besides patient insecurity, suffer-
ing, and an overload of work in therapy units, and the unsecurity felt by the 
nursing professionals who frequently feel overwhelmed, due to the lack of 
suitable strategies for these problems. The use of intravascular catheters has 
become a basic tool in hospital clinical practice and in oncological patient 
management, so that it becomes essential to follow a suitable praxis regarding 
the election of the most appropriate vascular access for each case. It is also 
of great importance to implement an appropriate education of the sanitary 
personnel, both at the patient evaluation phase as at the phase of already-
inserted catheter maintenance. For all these reasons, it is of vital importance 
to achieve full compliance of the CVC with the purpose and characteristics 
of the prescription, both for substance administration as for blood sample 
extractions, what constitutes one of the essential requirements in order to 
minimize patient suffering as well to provide him/her with better comfort. 
In the case of chemotherapy applications, priority must be given to a non-
peripheral administration of this. This bad practice gives place to an important 
life-long loss in venous patient health, with the subsequent diminishment in 
his/her quality of life. Method The election of the suitable device is directly 
related to therapy duration and to whether there is going to be a need of 
continuous vascular access or not. Patient safety will always be the priority 
so that the less damaging system will be chosen. It also will be taken into 
account the patient way of life and to what extent he/she is able to take care 
of his/her vascular access device. In the context of an acute process, which 
entails a long hospitalization time, this would give place to an indication 
of an external or percutaneous system, with one or two lumens, depending 
on whether the use of Parenteral Nutrition will be required or not. Once the 
acute process has been overcome, and depending on patient prognosis, it will 
be assessed whether to switch to a subcutaneous system might be advisable 
or not. Conclusions None of the different existing devices for vascular access 
are the perfect choice. Units must count with all the alternatives and must 
be well informed of all the advantages and disadvantages of the use of each 
36.
UsE of InTrAvEnoUs AnTIBIoThErApY AT hospITAL AT homE 
sErvIcE
García Domínguez, Maria Victoria; Garcia Berasaluce, Asunción; Herbosa 
Lopez, Ana; Basterretxea Ozamiz, Andima; Irurzun Zuazabal, Josu; Vazquez 
Vizcaino, Begoña; Salan Puebla, Jose Mª; Arroyo Herrero, Gloria
Osakidetza, Spain
Introduction: Outpatient parenteral antimicrobial therapy (OPAT) has been 
proven to be safe and effective on patients with several infection conditions. 
Hospital at Home Services are capable of attending all kind of pathologies, 
both medical and surgical. OPAT is one of the main activities of our Hospital 
at Home Service. The patients need in many cases intravenous antimicrobial 
therapy, either to complete the antimicrobial therapy initiated during the stay 
at the hospital or treatment initiated during the permanency with us. The aim 
of this work is to show our series of antimicrobial therapy administered at 
Home Service during 2009.
Patients and methods: Electronic information review about patients undergo-
ing intravenous antimicrobial therapy in the home setting during 2009 The 
following aspects were analyzed: age, diagnosis, therapy indicated, adminis-
tration type, intravenous access, complications with the catheters, and early 
discharge scheme. When we consider intravenous treatment at home will be 
very important to the choice of venous access depending on: the patient’s 
clinical condition, age, state of venous access, diagnosis, type and frequency 
of antibiotic administration, mode de administration (traditional or ambula-
tory infusion pump, length of treatment. Tables are designed to recommend 
the choice of catheter depending on the antibiotic to be administered, the 
duration of treatment and mode of administration. 
Results: 797 OPAT were indicated to 688 patients with a mean age of 67, 
49. Infections were more commonly found in skin and soft tissues (27, 32%), 
intraabdominal (22, 96%), respiratory (20, 80%), bacteremia (11, 72%), uri-
nary (6, 78%), bones and joints (4, 52%), other infections (5, 90%) A wide 
variety of antibiotics was used: 36,38% Ertapenem, 16,06% Piperacilina-
Tazobactam, 7.02% Daptomicina, 5,77% Teicoplanina, 3,76% Ceftazidima, 
3,76% Levofloxacino, 2,38% Cloxacilina, 24,87% other antibiotics 27, 73% 
of antibiotics were undergoing by mechanical infusion pumps, 72, 27% as 
monotherapy or intermittently. 1097 intravenous catheters were used, 86,69% 
peripheral catheters, 6,84% were central catheters, 4,28% were central cath-
eters with peripheral insertion and 2,19% Port-a-cath. The overall incidence 
of phlebitis was 9,48% , 14,31% flow back, 2,73% lost of catheter 0,73% 
catheter obstruction , 0,36 % associated bacteremia, and 0,09 break of cath-
eter The intravenous treatment lasted a mean of 11, 35 days which represents 
a decrease of 8,524 hospital stays. 
Conclusions: The intravenous antibiotic administration at home is effective 
and safe. This method of treatment satisfies the patient and permits hospital 
stays to be reduced thus improving the use of hospital
37.
pErIphErALLY InsErTEd cEnTrAL cAThETErs And mIdLInE 
cAThETErs As ALTErnATIvE vAscULAr dEvIcEs In chILdrEn 
sUBmITTEd To hEmATopoIETIc sTEm cELL TrAnspLAnTATIon for 
ThALAssEmIA
Roveda, A; Gallucci, C; Alfieri, C; Sodani, P; Paciaroni, K; De Angelis, G; 
Gaziev, J; Isgrò, A; Marziali, M; Lucarelli, G
MIH Foundation, Italy
Thalassemia is an inherited bone marrow disease requiring chronic long-life 
transfusions to treat the anemia caused by enhanced red blood cell destruc-
tion; this leads to progressive iron overload followed by organs deterioration. 
The only radical cure is haematopoietic stem cell transplantation (HSCT), 
which can give a very high rate of survival and disease-free life expectancy 
(1). To do this, patients submitted to HSCT need a specific central vascular 
access where all intravenous drugs and blood samples are given. In our insti-
tution, we perform at least three allogeneic bone marrow transplants monthly, 
all in pediatric patients coming from the Mediterranean areas in which thalas-
semia and some other haemoglobinopathies are endemic; given this, there is 
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Patient and Methods: Design: retrospective, cross-sectional study 
Setting: Patients referred to Hasheminejad Kidney center from year 2007 to 
2008 .224 patients with ESRD were included. 61%of the patients were male 
and the rest (39%) were female. The following information was collected for 
all these patients: BMI, sex, presence of HTN, DM, PCKD, type of kidney dis-
ease: obstructive kidney disease, glomerulonephritis, malignancy and coro-
nary artery disease (CAD). The frequency of each risk factor was determined 
separately. The data were statistically worked up. 
Results: The frequency of causes of CRF is as follows: DM, the most frequent 
cause (79.3%), HTN (64.5%), unknown causes (20%), obstruction(22%), 
PCKD(5%), GN(3%), malignancy(3%), CAD(9%), overweight (32%), obe-
sity(9%). 
Conclusions: In this study we examined a wide variety of risk factors, such 
as DM, HTN, BMI, CAD, malignancy, cystic kidney disease, age and sex. 
Overweight was interestingly a significant risk factor for CRF and ESRD. On 
the other hand, CAD was not found to be a significant factor, most probably 
because Hasheminejad Kidney Center is a specialized for kidney diseases. 
The same reason may be the cause of high prevalence for obstructive kidney 
problems in our series. The major limitations were unidentified risk factors 
of CRF and co- presence of multiple risk factors. However, this is a first step 
toward the development of a sketch to predict the likelihood of developing 
ESRD to be applicable to individuals with abnormal or even normal kidney 
function, such as potential kidney donors. In addition, the study adds to an 
accumulating body of evidence that risk factors other than just diabetes and 
hypertension, such as obesity may be causal in CKD. Future studies should 
examine the probable contributary mechanisms of those novel risk factors to 
CKD, and perhaps even test possible preventive measures.
41.
A mULTIcEnTEr prospEcTIvE EvALUATIon of ThE cLInIcAL 
pErformAncE of A 2% chLorhExIdInE gLUconATE 
AnTImIcroBIAL TrAnspArEnT Iv drEssIng 
Vlaminck, Hans1; Palka-Santini, Maria2
13M Heatlhcare WEMS, Belgium; 23M Healthcare, Germany
Introduction: The density of skin flora at the catheter insertion site is a major 
risk factor for CLABSI. The majority of CLABSI originate from the patient’s 
own skin flora. Among the strategies found to be successful in reducing 
CLABSI, the use of chlorhexidine has been included in the top five perfor-
mance indicators (recommendation CDC). Transparent dressings protect the 
insertion site and act as a barrier to external contamination, but allow visual 
inspection without removing the dressing. A new product has been devel-
oped that combines the benefits of a transparent dressing and chlorhexidine 
gluconate (CHG): a transparent dressing with an integrated gel pad which 
contains 2% CHG. The primary aim of this study was to evaluate the perfor-
mance indicators of the CHG antimicrobial transparent dressing (TegadermTM 
CHG) in clinical settings among skilled nurses: ease of dressing application 
and removal, adhesion and wear times, fixation and security of the catheter, 
protection of the CVC site. 
Method Study Design: A multicenter prospective study design was used. Dur-
ing a minimum 14 day period, nurses used the antimicrobial transparent ab-
sorbent gel dressing to cover the IV site instead of their current used dressing. 
Only adult patients with CVCs were included in the study. Outcome Mea-
sures: Primary endpoints: nurse evaluation of overall dressing performance. 
Secondary endpoints: ease of applying over IV Site, intuitive to use, time re-
quired to apply dressing, ability to visualize the IV site, ability to absorb fluid, 
ability to conform around and fixate the catheter, ease of removal from skin 
and catheter, patient skin condition after removal and overall adherence and 
wear time. The new dressing was compared with the current used baseline 
dressing using a five point Likert scale (1 to 5; much worse to much better). 
Facilities and Participants: 62 evaluators from 15 hospitals in 10 countries 
participated in the study (ICU, Dialysis, Oncology, General ward). 257 anti-
microbial dressings were applied and evaluated. 
Results • 88.89% of the evaluators rated the overall performance of the 
2% CHG antimicrobial transparent gel dressing as better or much better. • 
89.09% of the evaluators rated the wear time of the 2% CHG antimicrobial 
transparent gel dressing as better or much. • 94.12% of evaluators would 
one of them, depending on the clinical features of each patient. All systems 
potentially entail an additional risk, and health professionals should aim to 
minimize this risk by implanting the prescribed venous access as soon as 
possible, and by ensuring previous education of both the health professional 
and the patient.
39.
fAcTors compLIcATIng pErIphErAL vEnoUs AccEss In chILdrEn 
Cuper, Natascha1; de Graaff, Jurgen1; Verdaasdonk, Rudolf2; van der Werff, 
Desiree1
1University Medical Center Utrecht, Netherlands; 2VU Medical Center, 
Netherlands
Introduction: Potential risk factors for difficult venous access (BMI and a 
young age) are well known from experience, but literature evaluating these 
risk factors is sparse. In this study we evaluate predictive factors for single 
puncture rate and time of cannulation at four departments in a university 
children’s hospital. 
Methods: In a prospective cohort study, venous punctures were measured in 
pediatric patients at the operating room (OR; n = 1080), the daycare outpa-
tient clinic (n = 178), the outpatient phlebotomy station of the laboratory (n 
= 267) and children who were referred to the pediatric anesthesiologist, be-
cause their treating physician was unsuccessful in gaining intravenous access 
(n = 81). Time to successful venous access, single puncture rate (percentage of 
patients in whom the first puncture was successful) and potential risk factors 
(age, gender, skin color, BMI or weight-to-age z-score, anesthetized or not, 
grade of performer and type of surgery if applicable) were measured. A lo-
gistic regression analysis for single puncture rate was performed to determine 
predictive factors for difficult peripheral venous access.
Results: Mean time of cannulation was 123 s. Single puncture rate was 76%. 
Single puncture rate was lowest at the recovery (59%) and highest at the 
phlebotomy station (92%). The logistic regression showed that age, profession 
of the performer and type of surgery were predictive for single puncture rate 
at the OR (P<.001) and could explain 8.5% of the variance. A younger age, a 
profession other than anesthetic nurse and being scheduled for ophtalmology, 
maxillofacial surgery, neurosurgery and general surgery had a higher risk for 
an unsuccessful first attempt. At the phlebotomy station, a younger age and 
a dark skin color had a higher risk (P<.001) for an unsuccessful first attempt 
however, these factors only explained 7.4% of the variance. Age was also 
predictive for patients referred to the pediatric anesthesiologist (P=.002) and 
could explain 11.6% of the variance. No predictive factors were found for 
the daycare outpatient clinic. Contrary to general assumptions, the BMI or 
weight-to-age z-score was not found to be related to difficult venous access. 
Conclusions: Age and not BMI is a predictor for difficulties in gaining periph-
eral venous access. The present study shows that peripheral venous access is 
difficult in about a quarter of the patients and that cannulation is not very well 
predictable by easy accessible patient characteristics.
40.
rELATIvE frEqUEncY of rIsK fAcTors for chronIc rEnAL 
fAILUrE In 224 End sTAgE rEnAL dIsEAsE (Esrd) pATIEnTs, 
rEfErrEd for cAThETEr InsErTIon 
Khavanin Zadeh, Morteza1; Montazeri, Kamaneh2; Alemrajabi, Mahdi2
1Hasheminejad Kidney Center, Iran university of Medical Sciences, Iran, 
Islamic Republic of; 2Iran University of Medical Sciences, Iran, Islamic 
Republic of
Introduction: Chronic Kidney Disease (CKD) is defined as progressive loss of re-
nal function, most often leading to ESRD. CKD has been classified into 5 stages. 
The last stage in which the glomerular filtration rate (GFR) declines below 15ml/
min/1.73m^2 is known as ESRD. The present study assesses the frequency of 
different risk factors of CKD in the ESRD patients in order to emphasize on 
the relative importance of each risk factor to suggest a risk score for predicting 
the likelihood of developing ESRD and also calls on further studies to assess a 
causal relationship between the identified risk factors and ESRD. 
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would make these procedures accessible and easy to follow. 
Methods: A small group of nurses developed the hospital’s written proce-
dures into essential steps and determined the necessary images to accom-
pany the text. Photos were taken of each step. Draft photoguides were de-
veloped and distributed to key stakeholders for comment. Costings were 
obtained to produce colour laminated photoguides. Photoguides were 
attached to trolleys in each ward and the IVI team conducted informa-
tion sessions on their use. The success of the photoguides was assessed 
evaluating the number of consultations for related problems pre and post 
implementation, the number of staff attending education on the guides, 
and the condition and number of the guides still in place 3 months after 
implementation. Results The photoguides were rolled out to all wards in 
February 2010. Over the two month period following the implementation, 
there was an 80% reduction in the number of consultations for unblocking 
a CVC, a 37.5% reduction in consults for repairing a Groshong PICC, and 
71% reduction in consults for CVC dressings. At the end of March 2010, 
84 nurses had attended education sessions, and feedback at these sessions 
has been overwhelmingly positive. 
Discussion & Conclusion: Today’s hospitals have a high patient turnover 
with a shorter length of stay, with only very acutely ill patients treated as 
inpatients. This increased activity means that nursing staff have less time 
to wade through traditional procedure manuals. By introducing photogu-
ides attached to dressing trolleys, we have taken the procedure manual 
to the bedside where they are needed. We have shown that visual based 
procedures can be well accepted and reduce demands on a specialist IV 
access team.
44.
pErIphErALLY InsErTEd cEnTrAL cAThETEr In pEdIATrIcs
A conTrIBUTIon To cArE! 
Kok, Mariska I; van Dijk, Atty T.H
1University Medical Centre Utrecht, Netherlands
Introduction: Most children admitted to our hospital need vascular access 
for the administration of medication, fluids or TPN. Until recently the op-
tions were a peripheral venous catheter or a central venous line (CVL). 
Many children require repeated venapuncture due to small veins, length 
of therapy and/or administration of irritating fluids. This leads to anxiety 
and tissue damage. The alternative for repeated venapunctures is insertion 
of a CVL (jugularis, subclavian, Port a Cath, Hickman) often inserted by a 
surgeon or anaesthetist under general anaesthesia. We describe the intro-
duction and implementation of the peripherally inserted central catheter 
(PICC) which can be inserted under local anaesthesia. It can be used for 
short- to intermediate- term administration of irritating fluids, medication 
and blood withdrawal. 
Method: We initiated a project to introduce and implement the PICC. The 
project was financed by the University Medical Centre, with funds allocated 
for innovation in care. The aim was to use PICC’s in children where indicated. 
A dedicated team was assigned and a training program started. The project 
coordinator was responsible for training and education. She developed and 
implemented protocols and she can be consulted for further advise. PICC’s 
are inserted on the ward or in the treatment room of the daycare centre. 
Ultrasound-guided placement of PICC’s using the Modified Seldinger Tech-
nique makes it possible to insert the PICC in the upper arm (vena basilica). 
This location gives maximal range of movement. Indications, procedure and 
complications are registered. 
Results: In September 2009 the PICC team was formed. The team consists of 
two pediatricians, an anaesthetist and a PICU nurse (project coordinator). By 
January 2010 we were operational, at first under supervision and for a select-
ed patient group (over 10 years of age). Four months after take off we insert 
approximately 3 PICC’s a week. In the next months we expect this number to 
increase due to lowering the age of indication. A PICC line instead of frequent 
venapunctures with the above mentioned disadvantages means a better and 
safer quality of care. In some cases hospital admission was avoided or early 
discharge facilitated. Furthermore, we managed to achieve a reduction of 
the number of central venous lines placed under general anaesthesia, which 
enhanced the cost effectiveness of our project Way of insertion, reliability, 
recommend the 2% CHG antimicrobial transparent gel dressing. 
Discussion and Conclusion: The overall performance of the 2% CHG anti-
microbial transparent gel dressing was rated significantly better than their 
currently used baseline dressing. Physicians and nurses participating in this 
study were willing to replace their current dressing with the dressing under 
study. The 2% CHG antimicrobial transparent gel dressing was rated as better 
or much better in all of the specific performance comparison parameters.
42.
proTEcTIng ThE pUBLIc ThroUgh cErTIfIcATIon In 
vAscULAr AccEss: dEvELopmEnT of A crEdIBLE cErTIfIcATIon 
ExAmInATIon progrAm 
Haylock, Pamela1; Pettit, Janet2; Davis, Lois3
1Association for Vascular Access, USA; 2Vascular Access Certification 
Corporation, USA; 3Vascular Access Certification Corporation, USA
Introduction: In the United States, certification among health care profession-
als is designed to protect the public by identifying individuals who have cer-
tain knowledge and skills, most often in a defined specialty area. Certification 
programs are closely scrutinized and monitored by a number of voluntary 
organizations, but in general, certification criteria include a combination of 
education, experience requirements and examination. Though certification 
is voluntary, licensing entities and employers may choose to make it manda-
tory. Development of a customized credential occurs, among other reasons, 
because new technologies and procedures mandates a new scope of practice 
or body of knowledge: Such is the case in the vascular access arena. 
Method: Vascular access professionals have demanded a certification pro-
cess specific to the vascular access specialty for over a decade. Benefits of 
creating a recognized certification program to an existing association include 
enhanced visibility and recognition for the specialty, prestige, and a potential 
source of income for the association. There are also substantial economic and 
legal risks that make it imperative that credentialing organizations develop 
and implement programs in a credible fashion that minimizes liability. De-
velopmental steps include: 1) Needs assessment 2) Business Plan 3) Testing 
Company Selection Process 4) Job Task Analysis 5) Job Task Analysis Survey 
6) Develop test blueprint 7) Item Writer Selection, orientation and training 8) 
Item Writing Workshop 8) Test Item Analysis 9) Test Development 10) Beta 
testing 11) Cut Score Analysis 12) Test 13) Test analysis Results: This presenta-
tion provides an overview of certification program development undertaken 
in preparation for the launch of the first vascular access certification examina-
tion in December 2010. 
Discussion and Conclusion: Discussion topics include challenges, opportu-
nities, strategic and business planning legal issues, consideration of intrinsic 
and extrinsic motivators of potential certificants.
43.
ThE ImpAcT of UsEr-frIEndLY nUrsIng procEdUrEs on 
UTILIsATIon of A dEdIcATEd Iv AccEss TEAm 
Dobson, Pauline; Orford, Narelle; Mitchell, Sheree; Newbery, Alan; 
Benedetti, Michelle; Walpole, Sharon; Fallon, Emily; Cocking, Peter; Dibb, 
Jeanette; Loewenthal, Mark
John Hunter Hospital, Australia
Introduction: The IVI Team is a team of registered nurses who insert non-urgent 
intravenous cannulae (IVC) and peripherally inserted central catheters (PICCs) 
in a major metropolitan teaching hospital in Australia. Because of their ex-
pertise, nurses on the IVI Team are consulted on various aspects of peripheral 
and central venous catheter care. The number of consultations have increased 
over time, which reduces the time available for IVC & PICC insertion. Many 
of the consultations were for procedures that, with appropriate education, 
could be undertaken by all bedside nurses e.g. CVC dressings, unblocking a 
CVC, and repairing a Groshong PICC line. It was clear to members of the IVI 
team that a different approach from small group sessions was needed to reach 
larger numbers of nurses to increase their skills in CVC management. It was 
felt that visual procedure guides attached to dressing trolleys in every ward 
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46.
vEnoUs AccEss porT 
Melgårdshagen, Bente; Paulsen, Camilla; Kristiansen, Linda
OUS, Norwegian Radium Hospital, Norway
Introduction: Our hospital is renowned for its many years of work within 
both diagnosis and treatment of different types of cancer. The radiology de-
partment has contributed much to the efficiency of some of the procedures, 
for example relieving the anaesthetic and surgical departments of all venous 
access port implants. Indications for venous access port implantation are re-
peated intra- venous administration of chemotherapy, antibiotics, anti-viral 
drugs, parenteral nutrition, blood sampling or transfusion. The patient group 
are primarily breast cancer, gynecological cancer patients and various types 
of sarcoma. 
Method: The radiographer prepare lab and equipment prior to exam, posi-
tions patient, ensures EKG equipment and pulsoximeter are correctly in place 
and assist the radiologist during the procedure. First choice of catheter posi-
tion are vena jugularis interna dxt. because technical it’s easier to puncture 
as it’s more superficial and larger then the left one. Our section implants 220 
ports per year. 
Results: There are two main advantages of using the radiology department 
for the venous access port procedure: 1) Using ultrasound and fluoroscopy: 
patients no longer need narcosis, instead the procedure only requires local 
anaesthetic. 2) The use of these methods also increase accuracy in the loca-
tion and placing of the catheter and reduces complications such as pneu-
mothorax, air embolism, catheter disconnection or fragmentation, catheter 
rupture and haemothorax. 
Discussion and Conclusion: We experience less complications such as 
infections, fibrin sheath formation, catheter occlusion and pinch off since 
using vena jugularis interna instead of vena subclavia. - We experience 
only 1 or 2 port migrations each year. Our choice of catheter is the 8.5 
F silicone catheters as they tolerate certain contents of the chemotherapy 
better than polyurethan catheters. Silicone catheters can also be rinsed 
with ethanol if occlusion occurs. Most common complications today are 
badly placed venous access port needle, no back-flow, infections. How-
ever, we have few complications as a result of good routines, procedures 
and internal training.
47.
TrAInIng of nUrsEs In hIgh fLow pIcc cAThETEr mAnAgEmEnT 
BAsEd In oUTcomE IndIcATors 
 
Ruiz, Paloma; González, Juan Luis; González, Julia; Cubero, Maria Antonia; 
Montealegre, Maria; Rivas, Beatriz; Gallardo, Patricia
Hospital Clinico San Carlos, Spain
Introduction: 90% of hospitalized patients have IV device. According to sev-
eral studies, catheters are the most common cause of nosocomial infections 
(Crnich, 2005; Maki, 2006), because of its high prevalence it translates into 
longer median hospital stays, higher costs and 3% mortality rate (Gomez 
Luque, 2002), representing the 1st cause of death in cancer patients (Volkow, 
2000). Today, experts and the Center Disease Control (CDC) recommend the 
creation of vascular access specialized nurse teams (category IA) as an effec-
tive way to reduce these infections. Created in the U.S.A., IV Team or Intra-
venous Therapy Team (ITT) are composed of nurses experienced in the man-
agement and care of IV lines, trained in the insertion of peripherally inserted 
central catheter (PICC), with the support and coordination of the Vascular 
Radiology Department . 
Objective: To train and educate the intravenous Therapy Team nurses of the 
Hospital Clínico San Carlos in the placement / management and care of high 
flow PICCs, based on outcome indicators, demonstrating its cost effective-
ness / utility. 
Methodology: In 2009, High Flow PICCs were introduced to allow access to 
peripheral veins with a simple insertion technique using a microintroducer 
(micropuncture), our target were chronic patients dependent on central ve-
nous catheter or prolonged vesicant IV therapy. Although the project was 
presented for the first time in 2006 the creation of our I.V Team and its train-
and device comfort in addition to patient and staff satisfaction have led to the 
popularity of PICC’s. 
Discussion & conclusion: We describe an innovative project; introduction 
and implementation of the PICC in a Children’s Hospital. There was a per-
ceived need for PICC lines in our hospital but a lack of expertise and experi-
ence to insert them. Our hospital is the first hospital in The Netherlands to in-
troduce a dedicated team for PICC insertions in children. This has contributed 
to a higher quality of patient care.
45.
ToTALLY ImpLAnTABLE vAscULAr AccEss dEvIcEs for cYsTIc 
fIBrosIs: ExpErIEncE of An ITALIAn cvc-sErvIcE
Batacchi, Stefano1; Braccini, Gemma2; Bresci, Silvia3; Mostardini, Marco1; 
Proietti, Simone1; Cianchi, Giovanni1; Zagli, Giovanni1; Perretta, Lucia1; 
Peris, Adriano1
1Careggi Teaching Hospital, Italy; 2University of Florence, Italy; 3AOU Meyer, 
Italy
Introduction: Totally implantable vascular access devices are indicated 
and used in patients with cystic fibrosis to provide venous access for 
therapeutic administrations. The use of long-term central venous cath-
eters (LT-CVC) is reported to be associated with thrombosis (5-20%), in-
fection (10-15%) and mechanical complications (10-30%). The reported 
incidence of early complications (pneumothorax) has been reported 
to be 0.03-0.04/catheter placement, and for late complications about 
0.400-0.500/1,000 catheter-days, with thrombosis and infections preva-
lence (0.100-0.200/1,000 catheter-days). Ultrasound guidance has been 
suggested to reduce both early and late complication in LT-CVC posi-
tioning. Here we show our experience of 5 years of LT-CVC implantation 
in cystic fibrosis patients. 
Methods: The study was carried out by the Referral CVC service of the 
Careggi Teaching Hospital (Florence, IT) from 2004 to 2009 in collabo-
ration with the Referral Center for Cystic Fibrosis of Meyer Paediatric 
Hospital (Florence, IT). The following devices were implanted during 
the course of the study period: Titanium Dome Implanted Port (Bard 
Inc., Salt Lake City, USA) connected to 8 french Groshong® single lu-
men catheter. Implantation procedure was conducted under direct ves-
sels visualization with ultrasound portable devices (Site-Rite II-V, Bard, 
Pittsburgh, PA). Full aseptic conditions were observed according to 
operating-room protocols and asepsis was obtained with a 2% chlo-
rhexidine solution. The ultrasound probe was covered with a sterile 
latex-free ultrasound transducer cover kit. Local anesthesia (2% lido-
caine) was used to provide local anesthesia (vascular access, subcuta-
neous tunnel and pocket). The follow-up for catheter survival ended on 
March 1, 2010. 
Results: A total of 14 patients with cystic fibrosis underwent to Port 
positioning. Mean age of patients was 31 years old. The total number 
of catheter-days for all catheters was 10,700, with an average in situ 
catheter duration of 822 days. LT-CVC were all implanted in right inter-
nal jugular vein, and no perioperative complications (pneumothorax, 
hematoma, arterial puncture) occurred. Among late complications, one 
patient developed deep venous thrombosis within the first month after 
implantation. Other two patients underwent to catheter removal due to 
candida infection and catheter tip dislocation. Incidence of thrombosis 
and infection was 0.093/1,000 catheter-days. The overall rate of com-
plications was 0.280/1,000 catheter-days.
Conclusions: In our series, no early complications occurred using US-
guidance placement in cystic fibrosis patients, and also incidence of 
late complications in LT-CVC positioning resulted lower than previ-
ously reported. This observation might be ascribed to the ultrasound-
guided implantation procedure. No gram-negative infection occurred 
in our case series.
JVA_01_2011.indb   94 18-02-2011   14:31:16
95© 2011 Wichtig Editore - ISSN 1129-7298
Abstracts from wocovA 2010, 1st world congress on vascular Access, Amsterdam, The netherlands, June 16-18 2010
catheter-related complication (Total 
events pTc + hcw groups)
hazard ratio - hcw managed 
Lines (95% confidence interval)
Phlebitis (91) 2.06 (1.3 – 3.3)
Blockage (94) 1.06 (0.7 – 1.6)
Thrombosis (28) 2.8 (1.07 – 7.5)
Accidental Removal (25) 4.5 (1.34 – 15.2)
Suspected line infection (17) 0.95 (0.36 – 2.5)
Definite line infection (11) 0.13 (0.03 – 0.63)
49.
oUTcomE AnALYsIs In 3,160 ImpLAnTATIons of rAdIoLogIcALLY 
gUIdEd pLAcEmEnTs of ToTALLY ImpLAnTABLE cEnTrAL vEnoUs 
porT sYsTEms
Teichgräber, Ulf
Charité Universitätsmedizin Berlin, Germany
Introduction: Retrospective analysis of success and complication rates after 
radiologically assisted catheter port implantation. 
Method: Between 4/26/2000 and 11/3/2008, 3,160 port catheter systems 
were implanted in our interventional suite. The final follow-up deadline was 
12/31/2009. The indication for port implantation was impending chemother-
apy. All interventions were image guided - the puncture of the internal jugular 
vein (IJV) was sonographically assisted and the catheter tip position was con-
trolled with fluoroscopy. Catheter indwelling time and complication rates of 
peri-procedural, early and late complications were evaluated. 
Results: 922,599 catheter days (mean, 292 days) were documented. The im-
plantation was successful in 3,153 (99.8%) cases. A total of 413 (13.1%) 
adverse events were recorded. Of these, 42 (1.33%) were peri-procedural 
complications, of which 34 were treated successfully. 103 (3.3%) early and 
268 (8.5%) late onset complications occurred after port implantation. The 
most common complications were blood stream infection=134 (4.2%), 
catheter-induced venous thrombosis n=117 (3.7%), catheter migration n=41 
(1.3%) and fibrin sheath formation n=20 (0.6%). No pneumothoraces were 
recorded. A total of 194 (6.1%) port explantations were required. 
Conclusion: An ultrasound guided puncture technique, a central venous ac-
cess via the internal jugular vein and radiological guidance of the procedure 
contribute to low peri-procedural complication rates after port implantation. 
Typical complications associated with the surgical technique, such as pneu-
mothorax or pinch-off phenomena were not observed. We hereby conclude 
that an image guided implantation technique should be regarded as the meth-
od of choice for this procedure.
50.
ThrEE Uncommon compLIcATIons of cEnTrAL vEnoUs 
cAThETEr InsErTIon 
Monteiro, Cecilia
Instituto Português de Oncologia de Lisboa, Portugal
Introduction: The Vascular Access Unit performs over 600 Vascular Access-
related procedures a year, in an outpatient setting, under local anesthesia 
and fluoroscopic guidance. We report three uncommon late complications of 
central venous catheter insertion. 
Case 1: A 56 year-old female diagnosed with breast cancer metastatic to the 
pleura, liver and bone was referred to the Vascular Access Unit for recent 
catheter malfunction. The patient had a totally implanted port at the left sub-
clavian vein placed two years previously. Prior to catheter removal we per-
formed chest x-ray that revealed grade III Hinke pinch-off sign. We reviewed 
the patient’s previous x-rays and found lower grade pinch-off sign that had 
been unnoticed. The catheter fragment was removed by endovascular pro-
cedure. 
ing, was delayed due to pending evaluation of the health care impact and cost 
of this new technique. We designed outcome indicators to evaluate clinical 
care, activity, educational and costs. 
Results. Of a total of 45 catheters implanted, 30% of the patients achieved a 
positive response, eliminating repeated venipuncture, preserving their veins, 
increasing safety and welfare. 33% were removed after death, and 9% of pa-
tients were transferred to other centers and / or palliative care units and 4.2%. 
lost in follow up. A 3% withdrawn due to infection. The average survival time 
of implanted catheters was 25.58 days. Furthermore, PICCs translate into an 
inmediate saving of 161 € and 303.83 € with respect to Hickman catheters 
and ports. There is also an increase in saving over the peripheral catheter after 
90 days of implantation and 77 days with respect to CVCs, while helping 
reduce hospital stays and costs. Finally, 43% of the Oncology Unit Nurses 
(9 of 21) have been trained in the implementation, management and care 
of PICC’s. 
Conclusions: The creation of Intravenous Therapy Team in our hospital has 
shown to be cost-effective utility, reporting advantages and benefits to pa-
tients, health care professionals and the hospital itself. It also represents an 
improvement in the care and management of our resources.
48.
A compArIson of nUrsE vErsUs pATIEnT / cArEr AdmInIsTErEd 
homE Iv ThErApY 
Dobson, Pauline; Loewenthal, Mark; Orford, Narelle
John Hunter Hospital, Australia
Introduction: The Out & About IV Therapy Program provides home IV therapy 
(HIVT) for paediatric and adult patients in the Hunter Region, NSW, Austra-
lia. The majority of patients referred for HIVT require long term intravenous 
antibiotic therapy for serious infections. This HIVT is usually administered 
through a central venous catheter (99%) and over 85% of patients receive 
continuous infusions. Suitable patients and carers have the option to decide 
if they want to self-administer their HIVT. We studied whether patient / carers 
who self-care have equivalent outcomes to health care worker administered 
IV therapy. 
Methods: Data are entered into a computerised database in real time com-
mencing with admission to the HIVT service. Patients were divided into two 
groups: selected patients or carers who elected to administer their own infu-
sions or bolus injections and patients who had their HIVT administered by a 
health care worker, usually a visiting nurse. Readmission and early discharge 
rates and catheter complications that led to catheter removal were compared. 
Survival analysis techniques were used in Stata10.1 software. P-values were 
calculated using the Peto-Peto-Prentice test. Hazard ratios and 95% confi-
dence intervals were calculated using Cox regression. 
Results: 3316 admissions involving 74,124 patient days, were complete 
and included in the analysis. In the patient/carer (PTC) group there were 
1221 admissions (27,360 patient days), compared to the health care work-
er (HCW) group: 2095 admissions (46,764 patient days). PTC were less 
likely to be discharged early due to a complication (p=0.075). There was 
no difference in the rate of readmissions to hospital between both groups 
(p=0.85). The risk of developing a catheter-related phlebitis, thrombosis or 
accidental line removal was greater in the HCW group (Tab. I). There was 
no difference in the risk of catheter blockage or suspected line infection 
between both groups. The PTC group had a greater risk of definite line 
infection than the HCW group. This is entirely accounted for by a single 
patient with 4 infections. 
Discussion / Conclusion: Patients and their carers are able to administer 
home IV therapy with equivalent or better patient outcomes and lower com-
plication rates than healthcare worker administered HIVT. This reflects a 
high standard of selection and training provided by an experienced team, 
and also the potential for there to be a heightened sense of responsibility 
when caring for one’s own catheter. The advantages of patient/carer provi-
sion of HIVT are that it involves the patient actively in their own care, pro-
vides them with more flexibility of when HIVT is administered, and saves 
the cost of HCW time. This option should be considered for all services 
providing HIVT.
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This study compared the abilities of two different biguanide-based antimicrobial 
coatings to resist microbial adherence in vitro. 
Method: The antimicrobial catheters tested were a 7 French chlorhexidine 
and silver sulfadiazine (CHX/SS) coated CVC (Arrowguard Blue Plus®, Arrow 
International) and a 7 French chemically bonded polyhexamethyl biguanide 
(PHMB) CVC (Certofix Protect®, B. Braun). An untreated polyurethane (Con-
trol) CVC was used as a positive control. The method of Hanna et al. was em-
ployed to assess microbial adherence. Briefly, the catheters were aseptically 
cut into segments, presoaked for 24 hours in human plasma, then subjected 
to microbial challenge for 24 hours followed by recovery and enumeration of 
viable adherent organisms. Recovery was by sonication in neutralizing broth 
followed by serial dilution and plating on agar. Enumeration was performed 
by colony counting following 24 hours of incubation.
Results: Microbial recoveries for the three different catheters are presented in 
the Table below. Testing was performed in triplicate and individual replicates 













S. aureus 3.3 E+6 4.8 E+6 7.3 E+6 5.3 E+6 0 0
(ATCC 33591) 6.9 E+6 4.5 E+6 0
4.3 E+6 4.1 E+6 0
C. albicans 4.8 E+4 5.1 E+4 1.2 E+4 8.9 E+4 0 0
(ATCC 10231) 8.4 E+4 6.3 E+4 0
2.0 E+4 9.0 E+4 0
P. aeruginosa 1.2 E+6 3.8 E+6 2.4 E+6 3.6 E+6 0 0
(ATCC 27853) 7.1 E+6 3.0 E+6 0
3.0 E+6 5.4 E+6 0
(where CFU/mL = colony forming units per milliliter; E+4 = multiplied by 
10,000 and E+6 = multiplied by 1,000,000). 
Discussion and Conclusion: The CHX/SS coated catheter has been extensive-
ly studied. The antimicrobial agents elute from the coating to the surface of 
the catheter. The agents are known to have antimicrobial activity against the 
three pathogens studied here. The PHMB treatment is reported to be covalent 
(chemical) attachment to the catheter and forms a non-eluting antimicrobial 
surface. Results of the antimicrobial challenges show that the tethered PHMB 
was essentially ineffective in reducing microbial adherence of SA, CA and PA 
in this study. Soluble PHMB is reported to have antimicrobial activity against 
all three pathogens tested.
53.
sUrvEY on 1.010 sKIn TUnnELLEd cEnTrAL vEnoUs cAThETErs 
(hIcKmAn-BrovIAc) In 840 chILdrEn In A pEdIATrIc hAEmATo-
oncoLogY UnIT 
De Porre, Johan1; Van de Velde, Véronique2; Van Renthergem, Katrien1; 
Verlooy, Joris1; Dhooge, Katrien1; Benoit, Yves1
1UZ Gent, Belgium, 2University Hospital Ghent, Belgium
Objectives: To identify retrospectively benefits and problems of tunnelled cen-
tral venous catheters in children (0–17 year) treated for cancer and haemato-
logical disorders. 
Methods: Since 1991, data concerning type of device, number of catheter days 
and reasons for removal were recorded. Standard nursing procedures concern-
ing external fixation, flushing and management were introduced. 
Results: In 840 children 1.010 catheters were implanted, 70% of the patients 
received 1 catheter and 14,5% had 2 catheters. A total of 1002 were single 
lumen, 57 with an internal diameter (ID) = 0.7 mm, 945 with an ID = 1mm. 
Mean age at time of implant was 5.8 years (SD = 4.7). The total number of cath-
eter days was +/- 256.000 days; 174 catheters remained or are still functional 
for more than one year. At the moment of the survey (april 2009) 45 catheters 
were still in situ, one of them for more than 11.5 years. For removed catheters 
(n=965) the length of stay was 245 days; 776 catheters (80.4%) were removed 
as planned, at the end of treatment. The reason of removal for the rest (n=189) 
was: accidental removal (2.9%), occlusion (1.6%), infection (9,2%), leakage 
Case 2: A 19 year-old female with relapsing Acute Myeloid Leukemia was sent 
for placement of a short-term Vascular Access Device for induction chemothera-
py. After placement of a double lumen catheter at the right internal jugular vein 
she developed miosis and ptosis on the same side. The cervical CT scan showed 
correct catheter positioning and no hematomas, so the treatment was infused 
through the catheter with no further complications. There was gradual spontane-
ous resolution of the Claude Bernard-Horner syndrome in six months. 
Case 3: A 52 year-old male tongue cancer patient with multiple cervical e su-
pra-clavicular node metastasis needed a long-term Vascular Access Device for 
palliative chemotherapy. Due to non progression of the guidewire, it was im-
possible to catheterize the right subclavian and right internal jugular veins and 
the totally implanted port was placed at the left subclavian vein. Two months 
later the patient was referred to the Vascular Access Unit for a subcutaneus 
infiltrate surrounding the port. At surgical exploration a milky exsudade was 
found, with minimal inflammatory signs. The biochemical analysis of the fluid 
showed triglyceride count of 203 mg/L that prooved it was a lymphocutaneous 
fistula. There was spontaneous closure of the fistula after catheter removal. Dis-
cussion: Catheter fracture that may lead to embolization is due to mecanichal 
stress from compression between the clavicle and first rib. It occurs in under 
1,5% of patients. It can be prevented by detection of earlier pinch-off grades 
through chest x-ray. The Claude Bernard-Horner syndrome has been associated 
with central venous catheter insertion and is attributed to local anesthetic block 
of the cervical sympathetic chain or to its compression by hematoma, and it is 
usually self-limited. Lymphocutaneous fistula is a rare complication of central 
venous catheter insertion. It is due to iatrogenic disruption of the thoracic duct 
in patients with lymphatic or superior vena cava block.
51.
AccIdEnTAL pUncTUrE AccIdEnT rEdUcEd BY InTEnsIvE 
ImpLAnTATIon of cEnTrAL vEnoUs AccEss In A gEnErAL 
hospITAL 
Mussa, Baudolino1; Garrino, Cristina1; Pischedda, Franco1; Vergnano, Paolo2; 
Palumbo, Anna1
1University of Turin, Italy, 2Work Medicine, Italy
In our hospital there are 27 divisions with 850 bed. Many on these are dedi-
cated for high specialist medical and surgical tratment, so often endovenous 
drugs are used. Nurses are employed to give therapy and so theyr activity 
often request needle use. From 2006 we start to implant PICC catheter in 
patients needing medium and long term therapy. Our hospital monitors con-
stantly accidental needle puncture in nurse and physician. real number is 
unknown because no all accidents are rightly indicated on clinical data. In 
2007 we implanted 589 central venous access with 236 PICCs. In 2008 the 
activity growth and arrived at 728 central venous access with 389 PICCs. 
In the same period we observed 96 accident for 2007 and 61 accidents for 
2008. The increment of 23% for the central venous access in general and 
64% for PICCs are correlated with a reduction of the number of accidental 
needle puncture of 36,5%. In our experience we can confirm that intensive 
use of PICC could reduced risk for working medical and nursing personal 
and could reduce time spent for every patient. Otherwise cost of procedure 
and device must be evaluated to obtain right indication for PICC placement 
at beginning of hospital stay.
52.
In vITro compArIson of AnTImIcroBIAL propErTIEs of 
TEThErEd And ELUTIng BIgUAnIdE cEnTrAL vEnoUs cAThETErs 
(cvcs) 
Steinke, Elaine; Moss, Shanna; Rosenblatt, Joel
1Teleflex Medical, USA
Introduction: Catheter Related Blood Stream Infections (CRBSIs) cause consider-
able healthcare impact. Staphylococcus aureus (SA), Candida albicans (CA) and 
Pseudomonas aeruginosa (PA) are significant gram positive, fungal and gram neg-
ative pathogens associated with CRBSIs. Antimicrobial CVCs have demonstrated 
promise in reducing CRBSIs by inhibiting colonization of catheters by pathogens. 
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E+6 = multiplied by 1,000,000 and E+7 = multiplied by 10,000,000. 
Discussion and Conclusion: The CS coated catheter has been extensively 
studied and completely inhibited attachment of viable organisms in this 
study. Silver sulfadiazine and chlorhexidine elute to the surface of the 
catheter and have antimicrobial activity against the three pathogens stud-
ied here. The S1 and S2 treatments eluting silver ions alone displayed a 
very slight inhibitory effect towards SA and CS and did not inhibit at-
tachment of PA. Inhibitory concentrations have been reported for silver 
ions against all three organisms; however, the inhibitory concentrations 
increase significantly when organic materials are present.
55.
sEnsorY pErcEpTIons of oncoLogY pATIEnTs UndErgoIng 
sUrgIcAL InsErTIon of A ToTALLY ImpLAnTABLE vEnoUs AccEss 
dEvIcE: A qUALITATIvE ExpLorATorY sTUdY 
Goossens, Eva1; Janssens, Christel2; Goossens, Godelieve2; Stas, Marguerite2; 
Moons, Philip1; Jérôme, Martine2
1Center for Health Services and Nursing Research of the University Leuven, 
Belgium; 2Universtity Hospitals Leuven, Belgium 
Introduction: This study aimed to explore and document subjects’ descrip-
tions of sensory perceptions experienced during the course of a totally im-
plantable venous access device (TIVAD) insertion under local anesthesia. 
Methods: A qualitative exploratory study was conducted in which semi-
structured open-ended interviews were performed with 20 respondents 
who experienced a first time TIVAD insertion under local anesthesia. 
Immediately after the procedure, patients were asked to describe per-
ceived sensory perceptions regarding hearing, sight, touch, smell and 
taste. Descriptions of respondents were documented in a Sensory Infor-
mation Grid. This grid was composed of the 4 phases of a TIVAD inser-
tion and the 5 human senses. Verbatim descriptions of patients were la-
beled using a descriptive coding process supervised by an expert panel 
concerning surgical TIVAD insertion and nursing research. 
Results: This study demonstrated that patients experience a lot of sensory 
perceptions during surgical insertion of a TIVAD. Most sensational percep-
tions were experienced during the preparation of the patient and surgical 
equipment until covering the patient with sterile drapes (phase 2) and the 
TIVAD insertion until uncovering the drapes (phase 3). Patients experienced 
less sensations concerning smell. No perception of taste was mentioned. 
Conclusions: Patients report a lot of sensory perceptions during surgi-
cal TIVAD insertion under local anesthesia. Utilization of a sensory in-
formation grid to explore and document patients’ sensory perceptions 
emerged to be a suitable methodology. Reported descriptions could be 
used to develop a questionnaire to quantitatively assess sensory percep-
tions or could be implemented in preparatory sensory information to 
prepare patients for the upcoming surgery.
(1.2%) or a combination (4.7%). The latter catheters were nevertheless func-
tional for about 200 days. The durability of small catheters (< 1mm ID) was 
unfavourable compared to the group of 1mm ID (p = 0,0001). Only 49% stayed 
in the patient until end of therapy. The mentioned reasons for early removal 
were twice as high. In contradiction with a previous survey (1991-1999, n=365 
catheters), trends were similar except for accidental removal which no longer 
occurred in small children (0-4y) shortly after insertion. 
Conclusion: Nursing standard procedures for management of Hickman-
Broviac catheters seem to be effective as 80.4% remain in situ as planned. 
Small catheters (< 1mm ID) should be avoided as much as possible. Nursing 
standard procedures will be adapted for small catheters.
54.
In vITro compArIson of AnTImIcroBIAL propErTIEs of ThrEE 
sILvEr-BAsEd cEnTrAL vEnoUs cAThETErs (cvcs) 
 
Steinke, Elaine; Moss, Shanna; Rosenblatt, Joel
Teleflex Medical, USA
Introduction: Catheter Related Blood Stream Infections (CRBSIs) are 
responsible for significant morbidity and mortality in hospitals. Attach-
ment and proliferation of microorganisms on catheter surfaces are gener-
ally seen as a prerequisite for bacteremia. Staphylococcus aureus (SA), 
Candida albicans (CA) and Pseudomonas aeruginosa (PA) are significant 
gram positive, fungal and gram negative pathogens associated with CRB-
SIs. Several antimicrobial CVCs containing silver are presently available 
in Europe that promise to reduce CRBSIs by interfering with the pathogen 
attachment and colonization process. This study compared the abilities 
of three different commercially available antimicrobial coatings contain-
ing silver to resist microbial adherence in vitro. 
Method: Three commercially available silver-containing antimicrobial 
CVCs were evaluated: one coated with chlorhexidine-silver sulfadiazine 
(Arrowguard Blue Plus®, Arrow International denoted CS), one contain-
ing nanocrystaline silver (Logicath Agtive®, Medex denoted S1) and one 
containing a silver-zeolite complex (Multicath Expert®, Vygon denoted 
S2). An untreated polyurethane (Control) CVC was used as a positive 
control. The method of Hanna et al. was employed to assess microbial 
adherence. Briefly, the catheters were aseptically cut into segments, 
presoaked for 24 hours in human plasma, then subjected to microbial 
challenge for 24 hours followed by recovery and enumeration of viable 
adherent organisms. Recovery was by sonication in neutralizing broth 
followed by serial dilution and plating on agar. Enumeration was per-
formed by colony counting following 24 hours of incubation. 
Results: Microbial recoveries for the three different catheters are pre-
sented in the Table below. Testing was performed in triplicate and indi-
vidual replicates as well as mean recoveries are presented (Tab. I).

















S. aureus 3.3 E+07 2.2 E+07 1.2 E+07 1.5 E+07 1.8 E+07 1.4 E+07 0 0
ATCC 33591 2.0 E+07 1.8 E+07 9.5 E+06 0
1.3 E+07 1.5 E+07 1.5 E+07 0
C. albicans 7.3 E+05 6.8 E+05 8.5 E+05 6.1 E+05 4.3 E+05 5.9 E+05 0 0
ATCC 10231 8.3 E+05 6.8 E+05 3.5 E+05 0
4.8 E+05 2.9 E+05 1.0 E+06 0
P. aeruginosa 2.0 E+07 1.2 E+07 2.7 E+07 2.3 E+07 1.1 E+07 1.9 E+07 0 0
ATCC 27853 7.6 E+06 1.5 E+07 1.2 E+07 0
8.4 E+06 2.6 E+07 3.3 E+07 0
TABLE I
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The following aspects were analyzed: Number and type of antibiotics admin-
istered during 2009, intravenous access, complications with the catheters. 
When we consider intravenous treatment at home will be very important to 
the choice of venous access depending on: the patient’s clinical condition, 
age, state of venous access, type of frequency of antibiotic administration, 
mode of administration traditional or ambulatory infusion pump, length of 
treatment. Tables are designed to recommend the choice of catheter depend-
ing of the antibiotic to be administered, the duration of treatment and mode 
of administration 
Results: 797 OPAT were indicated to 688 patients. 1076 intravenous catheters 
were used, 86,71% peripheral catheters, 13,29% were central catheters, of 
them (3,83% were subclavian, 1,62% femoral, 1,30% jugular, 2,73% Drum, 
1,52% PICC, 2,29% Por-a-cath .143 antibiotics were administered through 
central venous line 10,49% Ertapenem, 17,48% Piperacilina-Tazobactam, 
13,28% Ceftriaxona, 9,79% Daptomicina, 11,19% Cloxacilina, 11,19% Van-
comicina 4,20% Cefepima 4,90 Ceftacidima 4,20% Teicoplanina 13,28% 
other antibiotics The intravenous treatment lasted a mean of 13,90 days. The 
incidence of complications was 5,6 % , 2,79% catheter lost , 0,70% phlebitis, 
0,70 flow back, 1,41% fever. 
Conclusions: The use of central venous catheters is the best vascular access 
for administration of antibiotics at home, is safe and effective, with a low 
number of complications, Despite our still limited experience with PICC ,we 
believe which may be the best central venous access for our patients ,it can 
be inserted by nurses, providing safety and quality in our daily practice.
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Introduction: OPAT is one of the main activities of our Hospital at Home 
Service. The patients need in many cases intravenous antimicrobial therapy, 
either to complete the antimicrobial therapy initiated during the stay at the 
hospital or treatment initiated during the permanency with us. Good choice 
of catheter will determine the success of the administration of intravenous 
antibiotics, preventing complications and preserving the patient’s venous 
capital. For the administration of certain antibiotics by their characteristics 
vesicant or irritant, it is essential to use a central venous line. The channeling 
of PICC is a technique still very new in our environment, but it can be done 
by nurses and ensuring a safe and reliable venous access. During 2009, we 
have started to insert PICC catheter in our Hospital at Home Service, so we do 
not have to resort to other professionals for the insertion of central catheters. 
The aim of this work is to show how many central catheters have been used at 
Hospital at Home Service during 2009 and complications detected. 
Patients and methods: Electronic information review about patients under-







< 1 week < 1 week 1-2 weeks 1-2 weeks 3-4 weeks 3-4 weeks > 4 weeks > 4 weeks
ANTIBIOTIC INFUSION PUMP TRADITIONAL INFUSION PUMB TRADITIONAL INFUSON PUMP TRADITIONAL INFUSION PUMP TRADITIONAL
Aciclovir CM CCCO CM CM CM CM CC CC
Anfotericina B CM CC CC CC
Amikacina CM CCO CM CM CM CM CC CC
Amoxi-
clavulánico
CCO CM CM CC
Ampicilina CM CM CM CM CC CC CC CC
Caspofungina CM CC CC CC
Cefepima CM CCO CM CM CM CM CC CC
Cefotaxima CM CCO CM CM CM CM CC CC
Ceftacidima CM CCO CM CM CM CM CC CC
Ceftriaxona CC CCO CM CM CM CM CC CC
Ciprofloxacino CM CM CC CC CC CC CC CC
Claritromicina CM CM CC CC
Clindamicina CM CCO CM CM CM CM CC CC
Cloxacinlina CM CM CC CC CC CC CC CC
Daptomicina CCO CM CM CC
Ertapenem CCO CM CM CM
Fluconazol CM CM CM CC
Ganciclovir CM CM CM CM CC CC CC CC
Gentamicina CM CCO CM CM CM CM CC CM
Imipenem CCO CM CM CC
Levoflozacino CCO CM CM CM
Linezolid CM CCO CM CM CM CM
Meropenem CCO CM CM CC
Metronidazol CM CCO CM CM CM CM CC CC
Penicilina G 
Sodica
CM CM CC CM CC CC CC CC
Piperazilina-
Tazobactam
CM CCO CM CM CM CM CC CC
Teicoplanina CCO CM CM CM
Tigeciclina CCO CM CM CC
Tobramicina CM CCO CM CM CC CC CC CC
Vancomicina CM CM CC CC CC CC CC CC
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